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ABSTRACT 
 
ADAM DAVID GRACZ: Intrinsic and extrinsic regulation of potency in the intestinal 
stem cell niche 
(Under the direction of: Scott T. Magness, Ph.D) 
 
 
The intestinal epithelium is one of the most proliferative tissues in the adult body, 
undergoing near total renewal every 5-7 days. This remarkable turnover is driven by a 
small population of intestinal stem cells (ISCs), which maintain the physiological 
function and epithelial barrier integrity of the small intestine, and initiate repair following 
damage. While the anatomical location of ISCs has been appreciated for decades, the 
complex genetics and cellular behavior of these cells is still the subject of intense 
research and debate. Emerging research shows that patterns of ISC proliferation and 
differentiation are governed by highly complex interactions between the extrinsic 
signaling of the ISC niche and intrinsic genetic programs that regulate ISC behavior on 
the cell-autonomous level. In this dissertation, we aim to address the regulation of ISC 
potency at the intrinsic and extrinsic levels. We describe technologic approaches for the 
isolation and in vitro culture of two distinct human ISC populations, as well as advanced, 
high-throughput culture conditions for the study of ISC-niche interactions. To address 
ISC potency from the perspective of intrinsic genetic programming, we examine the role 
of Sry-box containing 4 (Sox4), which we demonstrate plays a role in ISC differentiation 
and proliferation, possibly through epigenetic mechanisms. Together, these studies 
provide valuable tools for examining the effects of extrinsic signaling on ISC potency in 
vitro, as well as describe a novel mechanistic regulator of ISC differentiation. 
To my parents for their support and encouragement; to my friends and colleagues for 
their patience and assistance. 
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CHAPTER 1 
 
INTRODUCTION 
 
 
Intestinal epithelial structure and function 
 
The small intestine is a complex, multilayered tissue that is responsible for the 
processes of nutrient absorption and digestion critical for organismal survival. These 
layers consist of the intestinal mucosa, submucosa, muscularis, and serosa; each with a 
distinct cellular composition and function (Figure 1.1A&B). The intestinal epithelium, 
which is the central focus of this thesis, is a monolayer of columnar epithelium that lines 
the luminal surface of the small intestine and is responsible for a bulk of digestive 
processes. Additionally, since the intestinal lumen is constantly subjected to mechanical 
stress and ingested matter that may contain potential toxics and infectious agents, the 
epithelium provides an important barrier between the lumen and the body, and its 
integrity must be maintained in order preserve barrier function. The lamina propria lies 
immediately beneath the epithelium and consists mainly of fibroblasts, myofibroblasts, 
capillaries, and lymphocytes, which support the digestive and barrier function of the 
epithelium. Collectively, the epithelium and lamina propria form the intestinal mucosa. 
The outer layers of the small intestine, which include the submucosa, muscularis, and 
serosa, support the mucosa and contain the complex network of vasculature and nerves 
that regulate the movement of ingested matter down the gastrointestinal tract, and will not 
be further discussed here 1.  
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The intestinal epithelium is arranged along a crypt-villus axis (Figure 1.1C). The 
crypts, which exist as regularly dispersed invaginations in the epithelial monolayer, have 
long been appreciated as the proliferative compartment of the epithelium 2. A multipotent 
stem cell population, located at the base of the crypts, maintains the epithelium and drives 
near-total tissue renewal approximately every 5-7 days, making it one of the most 
proliferative tissues in the body 2. In addition to the intestinal stem cell (ISC) population, 
the crypts contain transit-amplifying progenitor cells (TA), which proliferate at a higher 
rate than ISCs, but exhibit a more restricted degree of potency and lack the ability to self-
renew under physiologic conditions 3. The villi, which serve as the main site of digestive 
function in the intestine, are made up mostly of absorptive enterocytes, with some 
secretory lineage cells (enteroendocrine and Goblet) dispersed throughout, but at much 
lower numbers 4-6. The crypts are largely devoid of post-mitotic, differentiated cells, with 
the important exception of Paneth cells, which are hypothesized to be produced in the TA 
zone and migrate to the base of the crypt, where they intercalate between ISCs 7, 8. 
Therefore, the hierarchy of proliferation in the intestinal epithelium flows from the ISCs, 
which divide relatively slowly, to the TAs, which undergo rapid, successive rounds of 
division and differentiation, to produce the post-mitotic cells of the villi. Because 
proliferation occurs continually in the intestinal epithelium, there is also a significant rate 
of cellular turnover. As they are produced in the crypts, cells migrate up the crypt-villus 
axis to the terminal end of the villus, where they are sloughed off into the lumen and 
undergo anoikis, a type of apoptosis that results from epithelial cells losing contact with 
their basement membrane (Figure 1.1C) 9. The kinetics of intestinal epithelial 
proliferation and migration were established by studies that used tritiated thymidine to 
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“pulse label” actively dividing crypt cells and track their migration by observation at 
different time points following thymidine administration, and have since been confirmed 
using non-radioactive thymidine analogues such as BrdU and EdU 10-12. 
 
In addition to established patterns of proliferation and migration, the 
differentiated cells of the intestinal epithelium have been well characterized by early 
studies into the cellular structure and function of the gastrointestinal tract 3-7. Post-mitotic 
lineages in the epithelium are subdivided into two main categories, based on specialized 
function: absorptive and secretory. Absorptive enterocytes make up the majority of 
epithelial cells in the villus, and are identified by their columnar morphology and 
expression of enzymes associated with digestive processes, such as sucrase isolmaltase 
(Sis) and lactase (Lct) 5. Secretory lineage cells are further subdivided into mucus-
producing Goblet cells, hormone-producing enteroendocrine cells, and Paneth cells. 
Paneth cells are unique among differentiated intestinal epithelial cells in that they reside 
exclusively at the base of the crypts. It has long been hypothesized that Paneth cells 
differentiate in the TA zone and migrate downward to the crypt base, though this has not 
been tested experimentally 7. The canonical function of Paneth cells is to secrete 
antimicrobial peptides into the intestinal lumen, to prevent extensive colonization by 
bacteria in the relatively sterile small intestine, as well as eliminate any ingested 
pathogens 13. In addition to their antimicrobial function, there is intense and growing 
interest in the potential function of Paneth cells as “niche”, or supporting, cells to the 
ISCs, which will be discussed in greater detail later in this thesis 8. Emerging research has 
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characterized a fourth secretory cell lineage, tuft cells, which are identified by expression 
of COX1, COX2, and DCAMKL1, though their precise function remains unknown 14, 15.  
 
 
Identification of intestinal stem and progenitor cells 
 
 Somatic stem cells are defined by their ability to meet the dual functional criteria 
of “stemness”: self-renewal, or the ability to produce a daughter stem cell, and 
multipotency, or the ability to produce all post-mitotic lineages in a given tissue. Its high 
rate of physiological renewal, coupled with well-defined post-mitotic lineages, makes the 
intestinal epithelium an attractive tissue for the study of somatic stem cell maintenance 
and differentiation. While the dynamics of intestinal epithelial turnover have been 
appreciated for decades, direct studies on ISCs were long hampered by a lack of specific 
genetic biomarkers. Until the recent identification of ISC biomarkers, two predominant 
theories existed concerning the location and properties of ISCs. Cheng and Leblond 
hypothesized that the crypt-base columnar cell (CBC), located at the basal end of the 
crypt and intercalated between Paneth cells, represented the ISC population, based on 
observations made by light and electron microscopy and evidence of proliferation 3, 5. An 
alternative hypothesis was generated based on early label-retention studies, which relied 
on tritiated thymidine-labeling followed by long “wash-out” periods to identify slowly 
dividing, or label retaining cells (LRCs, hypothesized to be stem cells), that were 
localized mainly to the “+4” position, relative to the base of the crypt 16, 17. Unification of 
the two theories on ISC position has resulted in the general acceptance of two potential 
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ISC populations: an “active”, rapidly-cycling ISC population of CBCs, and a “quiescent” 
LRC or reserve ISC population located at the +4 position 18. However, proving, 
disproving, or reconciling these theories remained a significant hurdle for the ISC field 
for decades, as technological limitations prevented the functional testing of stemness.  
 
In a seminal study, the G-protein coupled receptor Lgr5 (Gpr49) became the first 
ISC biomarker to be validated by in vivo lineage-tracing 19. Using a targeted knock-in of 
an enhanced green fluorescent protein (EGFP) reporter gene linked to tamoxifen-
inducible Cre recombinase by an insertional ribosomal entry site (IRES), Barker, et al. 
demonstrated that Lgr5 is expressed at high levels in CBCs, with low, but present 
expression in the TA region immediately above the Paneth cells 19. Importantly, lineage 
tracing using the Lgr5EGFP-CreERT2 allele demonstrated that derivatives of these cells were 
capable of forming long-lived clonal units that contained all post-mitotic lineages of the 
intestinal epithelium and persisted for 60 days or longer. These landmark studies 
established Lgr5 as a specific marker of CBC ISCs through the gold standard of in vivo 
lineage tracing, and resulted in the rapid identification and characterization of other CBC 
ISC biomarkers, including Olfm4, Ascl2, and Sox9 20-23. Further studies demonstrated that 
isolated Lgr5High cells were capable of forming structures containing all post-mitotic 
lineages of the small intestine, termed enteroids, in vitro 24, 25. In addition to the obvious 
biological implications of these studies, the development of the Lgr5EGFP-CreERT2 allele 
was an important technological contribution to the field, as it provided the first 
methodology for the isolation and downstream analysis of actively cycling ISCs. 
However, one important drawback of this mouse model is that the reporter gene is 
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expressed in a mosaic manner, with only some crypts exhibiting EGFP expression, 
despite the fact that Lgr5 is expressed in all intestinal crypts 19.  
 
The characterization of Lgr5 as an ISC marker was quickly followed by a “boom” 
in ISC biomarker discovery. In addition to the growing number of CBC ISC markers, a 
number of studies were published characterizing putative markers of +4 ISCs, the first of 
which was Bmi1. Like Lgr5, lineage-tracing experiments in Bmi1CreERT2 mice indicated 
that Bmi1+ cells are capable of forming long-lived clonal units that contain all post-
mitotic intestinal epithelial lineages in vivo 26. However, examination of Bmi1 expression 
by Cre induction in a Cre reporter mouse revealed that cells expressing Bmi1 are located 
primarily at the +4 position, which provided the first direct evidence for a secondary, +4 
ISC population in addition to the Lgr5+ CBC ISC 26, 27. Subsequent studies identified 
other genes associated with the +4 position that also functioned as ISC biomarkers in 
vivo, including mTert and Hopx 28, 29. The ErbB inhibitor Lrig1 was shown to be an ISC 
marker in vivo, but appears to be expressed at both the CBC and +4 positions, with 
conflicting reports highlighting the need for further study of this specific marker 30, 31. 
Interestingly, while all of the +4 ISC markers were shown to mark populations with some 
degree of stemness under normal physiological conditions, a majority of these studies 
also demonstrated increased lineage tracing from these markers following irradiation 
damage, resulting in a proposed model in which CBC ISCs represent an active stem cell 
population, and +4 ISCs are a reserve or quiescent population that activate to initiate 
repair following damage to the CBCs 27-29. This model is currently under intense scrutiny, 
19 
due to a recent report that Lgr5High ISCs are radioresistant and capable of initiating 
epithelial repair following irradiation damage 32.  
 
The extent to which CBC and +4 ISC populations are distinct from one another 
remains controversial. A recent study that analyzed transcriptomic and proteomic data 
from intestinal epithelial cell populations expressing variable levels of Lgr5 reported that 
all of the previously described +4 CBC markers were most significantly upregulated in 
the Lgr5High population, which was initially characterized as a CBC-specific marker 19, 33. 
Additionally, the study demonstrated that Bmi1 is not exclusively expressed in +4 cells, 
but is also present in CBCs, as well as the TA zone of the crypts 33. However, these data 
are subject to important caveats. The principle assumption of the Munoz, et al study is 
that Lgr5High expression is restricted to CBCs, and it is upon this assumption that the 
authors conclude that previously characterized +4 markers are most strongly expressed in 
CBC ISCs. It is possible that, depending on their functional status, some +4 ISCs may 
express upregulated levels of Lgr5 that are consistent with those found in CBCs. 
Examination of Lgr5EGFP expression reveals that some crypts do express high levels of 
EGFP in the supra-Paneth cell position 19, 34. This leaves open the possibility that 
heterogeneity within the Lgr5High population could bias gene expression data aimed at 
determining the existence of two distinct ISC populations. 
 
 Our group previously demonstrated that low levels of Sox9 expression are 
associated with actively cycling CBCs 21, 35. A Sox9EGFP BAC transgenic mouse was used 
to isolate cellular populations based on levels of EGFP expression, which faithfully 
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recapitulated expression of the endogenous mRNA and protein 35. Based on gene 
expression studies, we demonstrated that the Sox9Sublow population correlated with 
markers of TA cells; the Sox9Low population correlated with markers of actively cycling 
CBCs; and the Sox9High population correlated with markers of enteroendocrine cells, as 
well as previously described +4 ISC markers, including Bmi1, Hopx, and mTert 
(unpublished data and 21, 35). Furthermore, we demonstrated that enteroid-forming 
capacity in vitro was restricted to the Sox9Low population, consistent with the initial 
reports for Lgr5High cells 21. Compellingly, our gene expression data support a model in 
which CBC ISCs are distinct from +4 ISCs. That is, when isolating crypt populations 
based on Sox9EGFP expression, as opposed to Lgr5EGFP expression, the population 
expressing the highest levels of CBC ISC markers (Ascl2, Olfm4, and Lgr5) is 
genotypically distinct from the population expressing the highest levels of +4 ISC 
markers (Bmi1, mTert, and Hopx). Subsequent independent studies supported this 
observation, and demonstrated separation of CBC and +4 ISC marker genes between 
Sox9Low and Sox9High populations by RNA microarray, which also demonstrated 
differential clustering of the two populations by principal component analysis (PCA) 36. 
Compellingly, these studies also demonstrated that Sox9High cells were capable of forming 
enteroids in vitro following irradiation damage and partial gastrointestinal regeneration, 
consistent with Sox9High cells representing a reserve or facultative ISC population, the 
role classically attributed to the +4 ISC 36. Together, the emerging data on ISC biomarker 
and reported similarities and differences between CBC and +4 ISCs support a much more 
complex model for stemness and potency in the intestinal epithelium than originally 
postulated.  
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Stem cell plasticity and interconversion between CBCs and +4 ISCs 
 
Due to the complexities of reconciling myriad ISC biomarker studies, each 
focused on individual biomarkers, there has been intense interest in generating a unifying 
theory for how CBC and +4 ISCs contribute to maintenance of the intestinal epithelium, 
and if they function independently or in a cooperative manner. There is reasonable 
evidence that interconversion between CBCs and +4 ISCs occurs on a semi-regular basis, 
as Hopx+ +4 cells are capable of giving rise to Lgr5High CBCs both in vivo and in vitro 29. 
To further support the concept of ISC interconversion and distinct CBC and +4 
populations, Tian, et al demonstrated that Lgr5-negative, Bmi1+ cells were capable of 
maintaining intestinal epithelial homeostasis following complete ablation of Lgr5+ cells 
37. The group developed a novel Lgr5EGFP allele that also expressed the diphtheria toxic 
receptor (DTR). Importantly, this model exhibited constitutive expression of the knock-in 
gene across all crypts, unlike the mosaicism of EGFP expression seen in the original 
Lgr5EGFP model developed by Barker, et al 19, 37. The authors noted rare lineage tracing 
from Bmi1+ cells under physiological conditions, consistent with previous reports 26, 37. 
When mice were injected with diphtheria toxin, all Lgr5+ cells underwent apoptosis, and 
the number of lineage tracing events from Bmi1+ cells increased substantially 37. 
Surprisingly, there were no obvious defects in proliferation and differentiation following 
full ablation of Lgr5+ cells, though studies were limited to 5 days, due to organ failure in 
other tissues dependent on Lgr5+ populations 37. This study was the first definitive 
evidence that intestinal epithelial homeostasis is not dependent on the CBC ISC, and 
22 
supported the existence of multiple populations with stemness potential in the intestinal 
crypt.   
 
As an alternative explanation to the existence of two distinct ISC populations, 
emerging evidence suggests that the +4 population does not represent bona fide ISCs, but 
rather one or more populations of TA progenitor cells capable of dedifferentiating and 
adopting stem cell fate following damage. Early studies theorized that TA cells may be 
able to function as ISCs, and recent experiments have begun to support these hypotheses 
3, 38. In a recent study, the Notch ligand Dll1 was shown to mark a population of TA cells, 
concentrated around the +5 position 39. Under physiological conditions, lineage tracing 
from Dll1+ cells produced small, short-lived clones that contained secretory lineage cells, 
demonstrating that Dll1 marks TA cells committed to the secretory differentiation 39. 
However, when Dll1 lineage tracing was conducted following exposure to irradiation 
damage, the cells were able to function as ISCs, producing long-lived clones that 
contained both secretory and absorptive lineage cells 39. Labeling of Dll1+ cells 
immediately before irradiation produced these long-lived clones, but labeling 5 or more 
days prior to irradiation failed to produce any significant lineage tracing events 39. This 
final observation revealed another important characteristic of this facultative Dll1 
population, in that it is short-lived, and the window of time between cell “birth” and 
differentiation in which Dll1+ cells can dedifferentiate is limited to less than 5 days. 
While informative, this study did not address the possibility of a long-lived LRC that was 
capable of acting as an ISC.  
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A central problem in studying the functional output of the putative quiescent 
LRC, or +4 ISC, lies in the fact that label-retaining methods rely on the incorporation of 
thymidine analogues into DNA during S-phase. Unfortunately, all of these techniques 
require detection methods that must be carried out on fixed cells or tissue, precluding the 
ability to isolate LRCs for downstream culture and gene expression analysis. 
Furthermore, despite rapid and substantial ISC biomarker discovery, the overlapping 
expression and conflicting reports of ISC biomarker specificity resulted in no specific 
genetic signature that could be used to isolate LRCs. In a very recent and landmark study, 
Buczacki, et al employed an elegant strategy to genetically label LRCs through the use of 
a Cyp1a1-H2BYFP allele 34. In this model, expression of YFP is induced in all cells of the 
intestinal epithelium by injection of β-naphthoflavone (βNF), followed by a “washout” 
period, during which the YFP label is lost in short-lived, proliferating cells through 
multiple rounds of divisions and migration. The end result is retention of YFP expression 
exclusively in long-lived cells, effectively recapitulating label retaining studies that relied 
on thymidine analogues. Buczacki, et al found that the majority of LRCs were found at 
the +3 position following two weeks of post-induction washout 34. Interestingly, gene 
expression analysis of these cells revealed that while they expressed secretory lineage 
markers, they also shared significant overlap in highly expressed genes with Lgr5High 
cells, and in vitro culture demonstrated that they were capable of forming enteroids 34. 
Additionally, the authors demonstrated that LRCs contributed to the production of Paneth 
and enteroendocrine cells in vivo 34. In order to meet the “gold standard” of in vivo 
lineage tracing to demonstrate stemness, the authors developed a novel mouse model, in 
which one half of a dimerizable Cre recombinase was induced by βNF in the same 
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manner as in the Cyp1a1-H2BYFP model. This Cre was then present, but inactive, in LRCs 
following a washout period. Administration of a dimerizing agent, AP20187, caused the 
retained half of the Cre recombinase to combine with the remaining half, which was 
constitutively expressed, in order to induce recombination of a reporter allele 34. Using 
this model, which allowed the authors to lineage trace from functionally identified LRCs 
in the absence of genetic biomarkers, it was shown that LRCs were capable of acting as 
ISCs following irradiation damage, but not under normal conditions 34. Together with 
evidence from Dll1 studies, these results suggest that there are at least two populations of 
TA progenitors that have secondary potential as facultative ISCs: one that is short-lived 
(Dll1+), and one that is long-lived (LRCs). However, the comprehensive genetic 
signatures of these populations and the degree to which they overlap with populations 
identified by single canonical ISC biomarkers (Lgr5, Ascl2, Olfm4, Bmi1, Hopx, mTert, 
Lrig, Sox9) remains unknown. Further research is needed into the functional role of ISC 
biomarkers in potency and stemness, and may shed light into the cellular dynamics of 
ISC biology. These emerging data in the ISC field increasingly support a model in which 
multiple populations of genotypically and/or phenotypically distinct cells collectively 
share the burden of stemness.  Though not in direct conflict with earlier theories 
concerning ISC populations, recent studies suggest that ISC populations are more diverse 
and complex than originally thought. 
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Fate decisions and clonal expansion of intestinal stem cells 
 
In addition to efforts focused on the identification and characterization of ISC 
biomarkers, there is also a strong interest in understanding the proliferative dynamics and 
clonal behavior of ISCs. As stemness is characterized by a cell’s ability to self-renew and 
differentiate in a multipotent manner, the clonal behavior of a single ISC is the functional 
outcome of these processes as they pertain to the production and maintanence of a given 
tissue area. The survival of an ISC clone is entirely dependent on the ability of the 
parental ISC to self-renew and produce daughter ISCs that can continue to proliferate, 
differentiate and maintain the epithelial monolayer. Since inadequate or excessive self-
renewal could theoretically lead to a compromised epithelium or tumorigenesis, 
respectively, the cellular dynamics underlying ISC self-renewal and differentiation are 
critical in understanding intestinal epithelial homeostasis and disease.  
 
The classical model for self-renewal is invariant asymmetry, in which ISCs 
consistently divide to give rise to one progenitor cell, which will undergo one or more 
cycles of division and terminal differentiation, and one stem cell, which will serve the 
purpose of replacing the parent cell and maintaining homeostasis of the stem cell 
population (Figure 1.2A). This model was proposed as the mechanism for self-renewal in 
ISC populations, largely based on theoretical models of tissue renewal and maintanence 
of the stem cell pool 9. Potten argued against the term “self-renewal”, in that it could 
imply expansion of stem cell numbers, and instead employed the term “self-maintanence” 
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to describe the production of new stem cells without an overall net change in stem cell 
numbers 9. Additionally, Potten supported his model of invariant asymmetry by arguing 
that expansion of ISC numbers by symmetric division, while a feasible possibility in the 
context of tissue regeneration following damage, would be impractical under 
physiological conditions, as it would lead to aberrant tissue growth and, perhaps, 
tumorigenesis 9. It was acknowledged that an alternative model could exist, in which 
some ISCs divide symmetrically to produce two daughter ISCs (Figure 1.2B). This 
expansion could exist in homeostatic conditions under which the symmetric division of 
other ISCs toward differentiated lineages compensated for it, though Potten argued that 
this stochastic process would be subject to random and aberrant tissue loss and/or 
expansion since random shift in ISC population dynamics could be difficult to balance 
(Figure 1.2C) 9. Since these theories about ISC population dynamics and self-renewal 
were formed long before established ISC biomarkers, they remained impossible to test 
for some time. 
 
Taking advantage of the validated Lgr5 biomarker, recent studies have tested 
Potten’s hypothesis regarding invariant asymmetry and, surprisingly, demonstrated that 
the kinetics associated with clonal expansion driven by ISCs support a model of 
population asymmetry, also referred to as neutral drift 40, 41. In population asymmetry, 
stem cells divide stochastically, resulting in asymmetric division or symmetric division, 
producing either two stem cells or two differentiated progeny (Figure 1.2A-C) 42. To 
establish this experimentally, Snippert, et al generated a novel Cre reporter transgene, 
called R26-Confetti, based on the Thy1Brainbow allele. In both R26Confetti and Thy1Brainbow 
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mice, expression of Cre recombinase results in the removal of a floxed stop sequence 
preceding a number of different fluorescent protein reporter cassettes 41, 43. Opposing flox 
sequences flank these cassettes, such that Cre activity results in the random expression of 
a single fluorescent reporter. In the R26Confetti model, cells that undergo recombination 
can be labeled by GFP, RFP, YFP, or BFP 41. Importantly, as with lineage tracing, all 
progeny of these cells will express the same color as their parent cell. To test the kinetics 
of ISC self-renewal, Lgr5EGFP-CreERT2 mice were crossed to the R26Confetti allele, lineage 
tracing was initiated, and expansion of clonal units (independently identified by color 
differences) was observed at different time points following induction 41. Under the 
assumptions of the invariant asymmetry hypothesis, each ISC should expand clonally at 
approximately the same rate, such that each clone always contains a single ISC and 
persists over a long period of time to produce labeled, differentiated progeny. In this 
model, the number of clones observed at early time points post-induction would be 
equivalent to that observed at late time points, and all clones would expand at 
approximately the same rate. Surprisingly, Snippert, et al observed a decreasing number 
of clones over time, with increasing diversification of clone size 41. Through the 
application of mathematical modeling, the authors showed that the dynamics of ISC 
clone expansion followed neutral drift, an observation that was independently confirmed 
by another group that conducted similar experiments using a different genetic model for 
clone expansion 40, 41. These data are in direct conflict with Potten’s model of invariant 
asymmetry, and instead demonstrate that stochasticity in self-renewal is the predominant 
mode of ISC maintenance 9. Although some stem cells are lost to differentiation under 
this model, the net outcome of all stem cell divisions is the same as it would be under 
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invariant asymmetry and is sufficient to maintain homeostasis in the stem cell pool. In the 
absence of the present experimental validation of neutral drift ISC dynamics, logic would 
follow Potten’s original postulation that stochasticity in ISC self-renewal seems 
impractical 9. However, despite seemingly random expansion and loss of ISC clones, 
there appear to no pathological consequences to intestinal epithelial homeostasis. 
Therefore, rather than behaving in a manner consistent with cell autonomous asymmetry, 
ISCs exhibit the property of population asymmetry, in that the net outcome of all 
stochastic symmetric and asymmetric divisions is such that the overall number of ISCs in 
the intestinal epithelium remains at equilibrium. In further support of this model, a very 
recent study has demonstrated that only a minority of ISCs identified by the expression of 
ISC markers actually exhibits functional stemness in vivo 44. These data provide 
experimental validation of the self-limiting nature of population asymmetry in the 
intestinal epithelium.  
 
While these recent studies reveal that ISCs undergo clonal expansion patterns that 
are consistent with population asymmetry and neutral drift, it remains unproven whether 
the processes leading to this behavior are cell-autonomous or entirely influenced by the 
stem cell niche, the complex network of support cells that may provide fate-deterministic 
signals to ISCs. Though niches have been well described in other stem cell populations, 
especially in the hematopoietic system, little is known about the ISC niche 45, 46. Recent 
studies on the interaction between Paneth cells and ISCs have suggested that the former 
may provide critical mitogenic and morphogenic signals to the latter and greatly enhance 
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ISC survival and growth in vitro 8. This observation provides proof of principle that 
extrinsic factors can, at very least, significantly modulate ISC behavior.  
 
Regulation of proliferation and differentiation in the intestinal stem cell niche 
 
 Though much of our current knowledge surrounding molecular signaling 
networks in the intestinal epithelium precedes the advent of ISC biomarkers, there is a 
considerable amount of data concerning the various pathways that regulate proliferation 
and differentiation in the intestinal epithelium. The most substantially studied pathways 
pertaining to intestinal epithelial proliferation and differentiation are Wnt, Notch, and 
Bmp 47. The molecular functions of these pathways are reviewed at great length 
elsewhere, and will be summarized here 48-50. 
 
 The Wnt signaling pathway is one of the most comprehensively studied pathways, 
and provides many of the critical proliferative signals to stem and progenitor cell 
populations throughout a wide range of cell populations and tissues, both during 
development and in adult organisms. Canonical Wnt signaling occurs when WNT ligands 
interact with FZD or LRP receptors. This ligand-receptor interaction stabilizes the 
cytoplasmic protein β-catenin, which is normally bound to a destruction complex 
consisting of APC, GSKβ, AXIN, DVL, and CK1, which targets it for ubiquitinization 
and degradation by the proteasome. Receptor activation sequesters the destruction 
complex through direct interaction with LRP, and allows the accumulation of unbound β-
catenin in the cytoplasm. This free β-catenin then translocates to the nucleus, where it 
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derepresses the transcription factor TCF, and recruits myriad co-factors to activate 
context-dependent targets, generally associated with cellular growth and proliferation 
(reviewed by 48). In addition to canonical Wnt signaling, non-canonical Wnt signaling 
can be activated by WNT ligands, but induces downstream effects that are unique and 
independent from stabilization of β-catenin 51. Because proliferation is an important 
steady-state process in the intestinal epithelium, the Wnt pathway is especially active 
throughout adult life, and has been the subject of many studies aimed at understanding 
ISC biology. Additionally, mutations in the Wnt pathway are common across a wide 
range of cancers. Inactivating mutations in Apc are one of the most common mutations 
found in colorectal cancer (CRC), being detected in 85% of sporadic CRCs, and resulting 
in the aberrant accumulation of β-catenin due to defective destruction complexes 52-55.   
 
 Numerous studies have demonstrated that WNT is essential for the maintanence 
of ISC populations, and genomic analyses of the effects of disruption in Wnt signaling 
were the basis for early ISC biomarker discovery, as many ISC biomarkers are 
downstream targets of WNT/β-catenin. One of the most striking results from these early 
studies was the observation that complete loss of Wnt signaling, through genetic ablation 
of Tcf712 (which encodes the TCF4 protein), resulted in a lack of proliferation in vivo 56. 
Strikingly, the absence of Wnt signaling was sufficient to completely ablate ISCs, as 
Tcf712-/- mice died within 24 hr of birth 56. Histological examination of embryonic 
intestinal tissue showed a complete lack of proliferation in intervillus regions, which are 
analogous to crypts in the adult intestine, indicating a loss of the ISC population 56. 
Interestingly, the authors note that transition from endoderm to intestinal epithelium 
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occurs normally in both wild type and Tcf712-/- mice at E14.5, demonstrating that Wnt 
signaling is required for the establishment of ISCs and TAs, but dispensable for the 
formation of a differentiated epithelium 56. Later studies examined the role of Tcf1, Tcf3, 
and Tcf4 in adult murine intestine using conditional, floxed alleles, and demonstrated that 
loss of Wnt signaling through Tcf results in the loss of Lgr5/Olfm4+ ISCs in adult 
intestine 57. In addition to the establishment of intestinal crypts, it was shown that Wnt 
signaling is required for CRC cell proliferation through the expression of dominant-
negative TCF1 and TCF4 in CRC cell lines 58. Inducible expression of the dominant-
negative proteins was used to show that loss of functional TCF results in a depletion of 
canonical Wnt signaling, a halt in proliferation, and G1 cell cycle arrest in cell lines 58. 
The authors showed that loss of proliferation was due to decreased TCF4 signaling 
causing a decrease in C-MYC and subsequent depression of p21CIP1/WAF1, a cyclin-
dependent kinase (CDK) inhibitor 58. Importantly, these studies identified a number of 
direct genetic targets of Wnt signaling, which were in turn associated with ISC 
identification and function.  
 
Extending these findings toward the identification of broader genetic programs 
underlying the formation of ISCs, the Clevers lab conducted gene expression microarray 
on human colonic adenomas, which are known to have increased levels of Wnt signaling, 
and normal human colon, as well as several CRC cell lines expressing dominant-negative 
forms of TCF4 59. By comparing these analyses and localizing anatomical expression of 
significantly regulated genes to the crypt base, the authors generated a list of 17 genes 
that were regulated by Wnt signaling and represented a putative ISC signature 59. 
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Included in this list were Lgr5, Ascl2, and the subject of a portion of this thesis, Sox4 59. 
Further studies by the Clevers group demonstrated that, in addition to its role in ISC 
establishment and proliferation, Wnt signaling exerts an influence on cell position in the 
crypts. Dominant-negative TCF experiments by van der Wetering, et al. demonstrated 
that Wnt signaling positively regulated the expression of EphB receptors, while 
negatively regulating the expression of their ligands, ephrinB 58, 60. In normal tissues, 
Eph-ephrin interactions result in repulsive forces that effectively “sort” cells into discrete 
compartments. While EphBs and ephrinBs were expressed as an opposing gradient in the 
intervillus regions of normal embryonic intestines and adult intestinal crypts, they were 
absent in Tcf712-/- embryonic intestines 60. Genetic or pharmacological disruption of 
EphB expression in the intestine resulted in the displacement of Paneth cells, as well as a 
decrease in crypt proliferation, and less clearly separated proliferative and differentiated 
zones between the crypts and villi 60, 61.  
 
Recent studies have demonstrated that multiple sources in the intestinal 
epithelium produce WNT ligands, including the Paneth cells and mesenchymal cells of 
the lamina propria 8, 62. Paneth cells have been shown to produce sufficient niche signals, 
including WNT3, to support the growth of isolated ISCs in vitro, but appear to be 
dispensable for ISC survival in vivo 63, 64. A series of in vitro co-culture experiments 
demonstrated that Wnt signaling can also be supplied to ISCs by subepithelial intestinal 
myofibroblasts (ISEMFs), providing a partial explanation for the persistence of ISCs in 
the absence of Paneth cells 62. Interestingly, Wnt signaling also appears to drive 
differentiation of Paneth cells, an unexpected result since Wnt/β-catenin is most often 
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associated with proliferative cell populations 62, 65. Several Paneth cell genes are 
dependent on Tcf4 signaling, and proper Paneth cell differentiation and localization to the 
crypt base is dependent on expression of the WNT receptor Fzd5 65. Together, these data 
demonstrate that WNT provides a significant mitogenic and morphogenic signal in the 
intestinal epithelium that is critical to ISC survival and proliferation. Additionally, Wnt 
signaling works in a highly context-dependent manner, directing ISC self-renewal and 
proliferation, while simultaneously controlling Paneth cell differentiation. Wnt signaling 
appears to arise from cells that constitute the ISC niche, including ISEMFs and Paneth 
cells, suggesting that dynamic crosstalk between the intestinal epithelium and its 
underlying mesenchyme is critical for controlling ISC self-renewal and differentiation.  
 
While much less is known about the role of Bmp signaling in the intestinal 
epithelium, evidence suggests that this pathway provides pro-differentiation cues that 
serve as a counterbalance to Wnt-induced proliferation. BMP proteins belong to the TGF-
β superfamily, and act by binding to type II and type I serine/threonine kinase receptors, 
which form heteromeric complexes and activate downstream transcriptional effectors 
belonging to the Smad family 66. Mutations in the Bmp pathway, both at the receptor 
(BMPR1A) and effector (SMAD4) level, are associated with juvenile polyposis 
syndrome, a heritable disorder that predisposes individuals to gastrointestinal cancer 67, 68. 
In the intestine, Bmp4 is strongly expressed by the mesenchymal cells immediately 
underlying the epithelium, suggesting that these stromal cells play an important role in 
the induction of epithelial differentiation 69. As expected, Bmp4 is most strongly 
expressed in the villus mesenchyme, with only a few ISEMFs expressing the transcript in 
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the crypt mesenchyme 69, 70. One of the most compelling studies demonstrating the role of 
Bmp signaling in the intestinal epithelium employed the use of transgenic mice which 
over-expressed Noggin in epithelial cells 69. TGF-β inhibitory proteins, such Noggin, can 
negatively regulate Bmp signaling. Upon overexpression of Noggin in the epithelium, 
Bmp4 signals from the mesenchyme were effectively inactivated, as measured by a 
reduction in SMAD phosphorylation, a downstream effect of Bmp4 signaling 69. The 
striking physiological consequence of this inhibition was the de novo formation of crypts 
along the length of the intestinal villi, which the authors likened to the hyperplastic 
growth observed in patients with juvenile polyposis syndrome 69. Further studies 
examined the role of Bmpr1a in the intestinal epithelium through genetic ablation. 
Surprisingly, while these studies produced defects that included increased epithelial 
proliferation and decreased differentiation that eventually led to a polyposis phenotype, 
they did not phenocopy the severe de novo crypt phenotype observed by Haramis, et al 70, 
71. Together, these studies suggest that the severe phenotypes associated with clinical 
polyposis disorders are the result of multiple mutations in the Bmp signaling pathway, 
which plays a major role in regulating intestinal epithelial proliferation through the 
induction of differentiation 67-71. Genetic evidence indicates that the opposing regulatory 
elements of Wnt and Bmp signaling may act through extensive crosstalk, as a number of 
loci containing regulatory response elements for both Wnt (Tcf/Lef) and Bmp (Smad) 
have been identified 72. 
 
In addition to the relatively long-range cell-cell signaling provided by Wnt and 
Bmp pathways in the intestinal epithelium, Notch provides localized signals that regulate 
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cell fate and differentiation through direct cell-cell contact. Notch receptors and their 
ligands, which belong to the Delta/Serrate/Lag-2 (DSL) family, are both expressed on the 
cell surface and, unlike Wnt and Bmp signaling, require direct contact between 
neighboring cells to induce regulatory responses 50. Interaction of Notch receptors and 
DSL ligands induces the release of the Notch intracellular domain (NICD) through 
cleavage by ADAM family metalloproteases, which allows NICD to localize to the 
nucleus and interact with cofactors to induce transcriptional responses 50. In addition to 
trans signaling, Notch receptors and ligands expressed on the same cell exhibit cis 
inhibition through unknown mechanisms 50. Cis inhibition is thought to preserve the 
integrity of the trans Notch signal, by ensuring that both neighboring cells do not activate 
the downstream pathway. In the intestinal epithelium, Notch signaling is mainly 
restricted to the crypts, which express Notch1 and Notch2 receptors, as well as Dll1, Dll4, 
and Jag1 ligands 73. Notch1/2 receptors are associated with ISCs, and appear to play 
important roles in ISC maintenance 74. Ablation of Notch signaling in the intestine, 
through genetic deletion of the NICD transcriptional cofactor, or pharmacologic 
inhibition of γ-secretase (which acts upstream of NICD) results in a complete loss of 
ISCs, and conversion of a majority of crypt cells into differentiated Goblet cells 75. 
However, there appears to be some redundancy in Notch receptors and ligands, as dual 
deletion of Notch1 and Notch2 is required to convert proliferating cells to secretory 
lineages, and dual deletion of Dll1 and Dll4 is required to achieve the same effect through 
modulation of ligand expression 76, 77. These results point to a role for Notch signaling in 
ISC maintanence as well as secretory differentiation. Indeed, active Notch signaling 
results in the expression of the target gene Hes1, the loss of which results in increased 
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secretory lineage differentiation and decreased production of absorptive enterocytes 78. 
Loss of Hes1 can be partially compensated for by Hes3 and Hes5, and loss of all three 
intestinal Hes genes results in decreased proliferation, but does not fully ablate ISCs 79. 
Taken in context of the conversion of all proliferating cells to secretory fates following 
broad ablation of Notch signaling, these data suggest that other Notch targets may sustain 
ISC cell fate, while Hes1 is more important for absorptive lineage commitment. Olfm4, 
which is a CBC ISC marker, is also a target of Notch signaling and may be a candidate 
Notch-regulated effector of ISC fate 80. In addition to participating in absorptive fate 
specification, expression of Hes1 also results in the repression of transcription factor 
Atoh1, which drives cells toward enteroendocrine, goblet, or Paneth cell secretory fates in 
the absence of Notch signaling 78, 81. Loss of Atoh1 results in defective secretory lineage 
differentiation, and represents a reciprocal phenotype compared to loss of Hes1, 
strengthening the evidence for a balanced interaction between the two pathways in 
normal intestinal physiology 81. Therefore, the repression of Notch through cis inhibition 
or pharmacologic intervention results in early specification toward a secretory cell fate. 
Through this mechanism, Notch may provide contact-dependent regulation of ISC 
numbers in the intestinal crypts, by preventing two neighboring cells from adopting ISC 
fates. Interestingly, Paneth cells, which are intercalated between CBC ISCs, express DSL 
ligands, suggesting that they may contribute to the establishment of an ISC niche by 
providing trans-activation of Notch in ISCs 8. Additionally, cis inhibition by 
receptor/ligand interaction may help maintain or establish Paneth cell fates.    
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Studying intestinal stem cells in vitro 
 
 The inability to culture primary intestinal tissue, including ISCs, was a significant 
hurdle in the field of intestinal biology for decades. Due to the lack of an in vitro model 
system for studying ISCs, much of the early data regarding molecular signaling in the 
intestine relied on expensive and time-consuming in vivo mouse models, or CRC cell 
lines, which often fail to accurately recapitulate physiologically relevant properties. 
However, the increased understanding of signaling networks in the intestinal epithelium 
led to the development of a novel, three-dimensional culture system for intestinal crypts 
and primary-isolated ISCs 24. These culture conditions rely on the extensive use of small 
molecules and growth factors targeting the Wnt, Bmp, and Notch pathways. While 
originally established for murine small intestinal epithelium, these conditions have now 
been adapted and expanded to support the growth of murine colon and single colonic 
stem cells, human small intestinal, colonic crypts, and colon stem cells, as well as murine 
stomach and adenomatous tissue 24, 82, 83. Single isolated ISCs are capable of producing 
complex, multicellular organoids without the need for co-culture with ISEMFs 24. These 
long-lived structures, termed enteroids, produce crypt-like proliferative buds and contain 
all of the post-mitotic lineages found in the intestinal epithelium 24, 25. Significant 
modifications to the original growth factor cocktail used to support ISC growth has 
resulted in increased survival rates that potentiate expanded in vitro studies 84.   
 
 The ISC culture system is an invaluable technology that has been applied to 
elegant in vitro studies clarifying and supporting observations made in vivo. Our group 
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recently used the system to demonstrate that specific levels of the transcription factor 
Sox9 are associated with ISCs, TAs, and enteroendocrine cells 21. While in vivo lineage 
tracing remains the gold standard for establishing the stemness of cellular populations, 
the in vitro assay adds an additional level of precision for genes like Sox9, which exhibit 
broad but variable expression levels, in that lineage tracing is unable to distinguish 
between cell types based on gene expression level. Since the in vitro conditions result in 
the production of multipotent enteroids that can be maintained through multiple rounds of 
serial passaging, they provide an alternative platform that can be used to establish the 
stemness criteria of multipotency and self-renewal in isolated cells 21, 24. Additionally, the 
culture system has been used to demonstrate that Paneth cells are capable of supporting 
the development of ISCs into enteroids in vitro, suggesting that Paneth cells constitute a 
niche cell for ISCs 8. These experiments were in turn used as a basis to assess the effect 
of calorie restriction on ISC-niche interactions, which demonstrated that decreased 
caloric intake correlated with an increased ability of Paneth cells to promote enteroid 
formation from isolated ISCs 85. However, while the conventional system has facilitated a 
handful of functional experiments examining ISC biology, significant problems prevent it 
from being applied to elegant molecular and genetic assays 8, 36, 80. For one, simple 
quantification of ISC development into enteroids is significantly hindered by the three-
dimensional nature of the system and the tendency of cells to move through the 
extracellular matrix and fuse to form single enteroids from multiple cells 8. Additionally, 
Paneth cell co-culture experiments provide proof of principle that non-ISC cell types can 
considerably influence ISC behavior in vitro, raising significant concerns about cell-cell 
signaling in ISC culture assays and highlighting the need advanced technology aimed at 
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studying ISCs in vitro 8. Despite these limitations, the development of an in vitro culture 
system for ISCs has provided the field with a critical tool for examining and modulating 
the effect of extrinsic signaling on ISC stemness and differentiation. 
 
Sry-box (SOX) transcription factors and cellular potency 
 In addition to understanding how ISCs respond to extrinsic signaling cues, there is 
a strong interest in determining what intrinsic regulatory pathways affect stemness and 
how these cues prime ISCs for renewal or differentiation, as well as how they might 
become dysregulated in the context of cancer. The Sry-box (Sox) family of transcription 
factors is implicated in a broad range of developmental processes and, as such, is an 
attractive target for the study of intrinsic regulation of stemness in ISCs. Sox genes code 
for strongly conserved HMG-box containing proteins, that were originally identified in 
mammals through the discovery that Y-linked Sry is responsible for sex-determination 
and testicular initiation in embryos 86, 87. All other Sox factors are identified by homology 
to the SRY HMG-box, and further subdivided into specific classes by homology in 
protein structure and function 88, 89. Initially, 30 Sox factors were characterized, but 
redundancies between different studies and differences in nomenclature resulted in a final 
identification of 20 unique Sox factors 88, 90. All Sox factors share a HMG binding 
domain motif, and although compensation between Sox factors appears to be common, 
especially between members of the same subfamilies, it appears that interaction with 
binding partners helps direct individual Sox factors to specific transcriptional regulatory 
sites 88, 89, 91. Beyond classical roles in trans-activation and repression, Sox factors possess 
the capacity to direct dramatic conformational changes in chromatin structure through 
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binding the minor groove of the DNA helix and bending chromatin 92, 93. These 
conformational effects on chromatin structure have been shown to be essential for sex-
determination by Sry and are thought to function through joining enhancer and promoter 
regions that are normally separated by large distances across the genome 91, 94. Because 
Sox factors share a common binding motif, functional compensation has been observed 
between several pairs of Sox factors. Both Sox5 and Sox6 are independently dispensable 
for chondrogenesis, but genetic deletion of both results in defective cartilage formation 95. 
Similarly, Sox4 and Sox11, which both belong to the SoxC subfamily, exhibit 
overlapping expression in the developing nervous system and can compensate for one 
another in spinal cord development 96.  
Sox factors are generally studied in the context of broad transcriptional regulatory 
programs, are known to regulate diverse cellular processes such as proliferation, 
differentiation, and apoptosis, and are found in stem cell populations throughout the 
body, both during development and in adult tissues 97. Sox2 is one of the most studied 
Sox factors, as well as one of the master regulatory transcription factors involved in 
maintaining embryonic stem cell (ESC) identity 98. Additionally, Sox2 is one of the four 
transcription factors, along with Oct4, c-Myc, and Klf4, that together are capable of 
reprogramming post-mitotic cells to an induced-pluripotent stem cell (iPSC) state 99, 100.  
POU domain proteins, such as OCT4, are well-characterized binding partners for Sox 
factors, and the synergistic power of Sox2-Oct4 in programming cellular potency has 
been demonstrated by the ability of these two factors to generate iPSCs in the absence of 
Klf4 and c-Myc, through the combined used of a histone deacetylase (HDAC) inhibitor 
101-103. As development proceeds, Oct4 may partner with different Sox factors to promote 
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specification toward tissue-specific genes. For example, during the generation of cardiac 
progenitors from iPSCs, Oct4 switches from driving Sox2 expression to driving Sox17 
expression, which results in the promotion of an endodermal cell fate 104. Further studies 
into the interaction between Sox2 and Oct4 have yielded significant insight into 
specificity and redundancy between Sox factors. Under normal conditions, SOX2 and 
SOX17 both act as OCT4 cofactors, but SOX2-OCT4 targets remain distinct from 
SOX17-OCT4 targets 105. Substitution of a single amino acid in the OCT4-interaction 
domains of SOX2 and SOX17 reverses this specificity and results in a novel SOX17 
protein that is capable of inducing pluripotency, and a novel SOX2 protein that is capable 
of activating genes associated with endodermal specification 105. Expanded studies 
revealed that similar results could be achieved by modifying SOX7, but not other Sox 
factors, though further modification of C-terminal transactivation domains could confer 
some reprogramming function to SOX4 and SOX18 106. Together, these studies indicate 
that Sox factors have strong potential for directing genetic programs associated with 
stemness and potency, and despite having similar binding motifs, possess context-
dependent capabilities based on association with partner proteins.  
Sox factors are expressed throughout the gastrointestinal tract, and play important 
roles in the developmental and stem cell biology of the esophagus, stomach, small 
intestine, colon, pancreas, and liver 107. Sox9 is the most comprehensively studied Sox 
factor in the small intestine, and has been shown to have important roles in both ISC 
proliferation and differentiation, consistent with the broad functionality observed for Sox 
factors in ESCs and iPSCs. Sox9 is expressed throughout the intestinal crypts, 
encompassing ISCs, TAs, Paneth cells, and crypt-based enteroendocrine cells 20, 21, 35, 108, 
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109. Loss of Wnt signaling results in a total loss of Sox9 expression in the crypts, 
indicating that Sox9 is a Wnt target gene 108. Interestingly, Sox9 is expressed at different 
levels throughout the crypt, with Sox9Sublow expression marking TAs, Sox9Low expression 
marking ISCs, and Sox9High expression marking enteroendocrine cells 21, 35. Some 
Sox9High cells are present in the villi and express the enteroendocrine marker Chga, as 
well as the tuft cell marker Dclk1, though the heterogeneity of the Sox9High cells in the 
villus has not been fully examined 14, 15, 35. Interestingly, Sox9High cells in the crypts are 
commonly observed in the +4 position and express markers associated with reserve ISCs 
35, 36. Though normally not observed to be proliferative, the Sox9High cells of the crypt 
enter the cell cycle and are capable of forming enteroids in vitro following irradiation 
damage 36. Together, these data suggest that Sox9High cells are at least partially consistent 
with the LRC secretory precursors described by Buczacki, et al 34. Conditional genetic 
ablation of Sox9 specific to the intestinal epithelium results in crypt hyperplasia and 
reduced production of Paneth cells, demonstrating that Sox9 has a role in tempering 
proliferation in the ISC zone 108, 110. Overexpression of Sox9 in cell lines results in 
reduced proliferation and a endocrine-like phenotype, consistent with observations made 
in vivo 35, 110. Despite the phenotypic changes in Sox9 knockout mice, the animals are 
healthy and viable, with no overt deleterious effects, suggesting that compensation by 
other Sox factors may ameliorate genetic dysfunction in the absence of Sox9 110. A 
number of other Sox factors, including Sox4, Sox7, Sox17, and Sox18 are expressed in the 
adult intestinal epithelium, but their functions remain largely undetermined 111-114. 
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Sox4 as a regulator of development and differentiation 
 
 Sox4 has been studied mainly in the contexts of hematopoietic and neural 
development. It was originally established as a lymphocyte-associated transcription factor 
expressed in T and pre-B lymphocytes as well as the thymus, and was shown to have 
potent transactivating capabilities that led to the conclusion that Sox4 might be important 
for the establishment of cell fate in lymphocytes 115, 116. Later, Sox4 was established as a 
critical factor in cardiac development, as mice carrying constitutive deletion of Sox4 die 
at E14.5 due to significant defects in the cardiac outflow tract, which resemble common 
arterial trunk defects in humans 117. Consistent with its early association with 
lymphocytes, hematopoietic cells isolated from Sox4 knockout embryos and transplanted 
into wild-type recipients produced fewer numbers of pre- and pro-B cells, but normal 
number of T lymphocytes 117. Despite the normal numbers of T lymphocytes in recipient 
mice following transplantation, further studies on thymic explant cultures from Sox4-/- 
embryos demonstrated decreased efficiency in T lymphocyte differentiation as well 118. 
Studies in adult mice demonstrated that induced ablation of Sox4 results in apoptosis and 
loss of pro-B cells, indicating that Sox4 plays an important role in fate specification in the 
hematopoietic system even after development 119. These phenotypic observations 
generated an interest in the mechanistic effects of Sox4 in B and T cell differentiation. 
Sox4 is known to be a target of TGF-β signaling in hematopoietic and neural tissues 120, 
121. Detailed studies into the role of Sox4 in T cell development showed that Sox4 is 
activated downstream of TGF-β to suppress differentiation into T helper type II cells, 
both by binding of SOX4 protein directly to GATA3, and by inhibitory binding of SOX4 
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to genes required for T helper type II cells 121. Through these mechanisms, Sox4 is able to 
effectively block Gata3-dependent T helper type II differentiation, both through classical 
transcriptional repression and by direct inhibition of the GATA3 transcription factor. In 
pre- and pro-B cell lineages, Sox4 was shown to bind and enhance the activity of the B 
cell-specific λ5-VpreB1 locus, providing mechanistic evidence for how Sox4 may specify 
B cell fate in hematopoietic precursors 122. Interestingly, this locus was bound by Sox2 in 
ES cells, where it carried histone marks associated with both active and repressed gene 
transcription 122. These combinatorial histone marks, known as bivalent domains, are 
associated with inactive, but primed transcription and are thought to represent regions of 
the genome that are prepared for rapid initiation of transcription following specific 
developmental cues 123. Loss of Sox2 was associated with a loss of the active histone 
mark in ES cells, and SOX4 colocalized with the same active mark in pre-B cells 122. 
Together these data implicate a Sox2-Sox4 cascade in the epigenetic regulation of B cell 
differentiation, suggesting that Sox factors may affect large-scale transcriptional changes 
associated with development and differentiation through epigenetic mechanisms. 
 
 In addition to its roles in hematopoietic differentiation, multiple studies have 
established Sox4 as a regulator of differentiation in the nervous system. In the neurons of 
the spinal cord, Sox4 exhibits overlapping expression with Sox11 and Sox12, which 
together constitute the SoxC subgroup of Sox factors 88, 96, 124. Together, Sox4 and Sox11 
activate a number of basic helix-loop-helix (bHLH) transcription factors that are 
associated with neural lineages and required for fate specification into terminally 
differentiated neurons 124. Since Sox4 and Sox11 activate neural bHLHs, they are 
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considered very early differentiation factors in neural development, a conclusion that is 
supported by the observation that a complex known to inhibit neural differentiation 
directly blocks expression of Sox4 and Sox11 in neural progenitors 124. Independent 
studies found that concomitant loss of Sox4 and Sox11 resulted in widespread apoptosis 
in the early neural tube, in addition to defects in organogenesis in cardiac, skeletal, and 
some abdominal organs 125. These studies were further supported by the observation that 
deletion of both Sox4 and Sox11 results in apoptosis in the developing spinal cord, but 
that individual deletion of each gene has no observable phenotypic effect 96. Expression 
of SOX4 and SOX11 was found to be restricted to neural progenitors, supporting a role 
for the factors as regulators of differentiation 96. Interestingly, loss of Sox4 and Sox11 in 
the sympathetic nervous system does not result in differentiation defects, but rather in 
significantly decreased progenitor proliferation 126. Perhaps more surprisingly, studies 
found a decrease in genes associated with myelin differentiation, severe hypomyelination, 
and ataxia in mice carrying transgenic overexpression of Sox4 in oligodendrocyte 
precursors 127, 128. Together, studies on Sox4 in the nervous system assign disparate roles 
for the gene in different cell and tissue types, with some lineages appearing dependent on 
expression of Sox4 for differentiation and others appearing to require downregulation of 
Sox4 before differentiation can take place. However, common themes are found in the 
restricted expression of Sox4 in progenitor populations, functional compensation for loss 
of Sox4 by other SoxC factors, and the general involvement of Sox4 in the process of 
differentiation.    
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In the gastrointestinal tract, Sox4 is most appreciated as an important regulator of 
endocrine differentiation in the pancreas 129, 130. Pancreatic explant cultures grown from 
Sox4-/- embryos exhibit decreased expression of insulin and glucagon, as well as key 
bHLH transcription factors required for endocrine differentiation, including Ngn3 and 
NeuroD1 130. In the intestinal epithelium, Sox4 was identified as a Wnt target gene in 
early studies examining the role of Wnt signaling in epithelial development and crypt 
formation 56, 59. Like Sox9, Sox4 is expressed in the base of the intestinal crypt, though the 
number of Sox4 transcripts per cell appears to be slightly lower than that of Sox9, based 
on single molecule fluorescent in situ hybridization (ISH) 131. Studies in CRC cell lines 
demonstrate that Sox4 positively regulates canonical Wnt signaling by increasing the 
activity of a TOP-flash reporter construct 114. In vitro studies also indicate that SOX4 
may bind directly to β-catenin and TCF/LEF proteins, suggesting that it may stabilize the 
former and act as a transcriptional cofactor with the latter 114. However, the role of Sox4 
in intestinal stemness and differentiation in vivo remains unknown. Though in vitro 
studies in cell lines can produce meaningful data aimed at understanding the molecular 
biology of signaling pathways, they often fail to recapitulate physiological conditions, as 
immortalized CRC cell lines carry multiple mutations that may not be found in normal 
tissue or even tumors in vivo. Additionally, CRC cell lines do not accurately model the 
compartmentalized proliferation and differentiation of the intestinal epithelium. Due to its 
complex and conserved role in differentiation during embryonic development and across 
multiple different tissue types, understanding the role of Sox4 in the intestinal epithelium 
may provide valuable mechanistic insight into the regulation of stemness and 
differentiation in ISCs. 
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Figure 1.1: Anatomy of the small intestine. The intestinal lumen is lined by a monolayer of columnar epithelial cells, called the 
intestinal epithelium, which is responsible for critical nutrient processing and barrier function (A). The intestine is a complex, 
multilayered tissue, with the lamina propria, muscularis, and serosa acting together to support the intestinal epithelium and aid in 
digestive and absorptive processes (B). The intestinal epithelium forms a regular micro anatomical landscape consisting of crypts and 
villi (C). New epithelial cells are produced by ISCs in the base of the intestinal crypts at a rapid rate under normal conditions. These 
cells then undergo multiple round of differentiation and lineage specification as they migrate toward the villus tip, where they are 
sloughed off after ~5-7 days and undergo programmed cell death, called anoikis (C). 	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Figure 1.2: ISCs can adopt asymmetric or symmetric fate decisions. Asymmetric division of ISCs results in self-renewal and 
differentiation, with the production of one daughter ISC and one TA progenitor (A). Symmetric division can result in either self-
renewal of ISCs (B) or loss of the clonal unit by differentiation into TAs (C). The mechanisms underlying each fate decision remain 
unknown. 
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CHAPTER 2 
 
CD24 AND CD44 MARK HUMAN INTESTINAL CELL POPULATIONS WITH 
CHARACTERISTICS OF ACTIVE AND FACULTATIVE STEM CELLS1,2 
 
 
OVERVIEW 
Recent seminal studies have rapidly advanced the understanding of intestinal epithelial 
stem cell (ISC) biology in murine models. However, the lack of techniques suitable for 
isolation and subsequent downstream analysis of ISCs from human tissue has hindered 
the application of these findings toward the development of novel diagnostics and 
therapies with direct clinical relevance. This study demonstrates that the cluster of 
differentiation genes CD24 and CD44 are differentially expressed across LGR5 positive 
“active” stem cells as well as HOPX positive “facultative” stem cells. Fluorescence-
activated cell sorting enables differential enrichment of LGR5 cells (CD24-/CD44+) and 
HOPX (CD24+/CD44+) cells for gene expression analysis and culture. These findings 
provide the fundamental methodology and basic cell surface signature necessary for 
isolating and studying intestinal stem cell populations in human physiology and disease.
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 previously published material: John Wiley & Sons, Inc., used with permission. The 
original citation is as follows: Gracz, et al. “CD24 and CD44 mark human intestinal cell 
populations with characteristics of active and facultative stem cells”, Stem Cells 31:9, 
2024-2030. 
 
2 full list of contributing authors: Gracz AD, Fuller MK, Wang F, Li L, Stelzner M, Dunn 
JCY, Martin MG, and Magness ST. 	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INTRODUCTION 
Lgr5 was the first validated ISC biomarker shown to be expressed in actively cycling 
mouse crypt base columnar cells (CBCs) 19. Subsequent studies demonstrated a 
secondary, “reserve” population of mouse ISCs marked by Bmi1, Hopx, mTert, and Lrig 
27-30. Emerging evidence indicates overlapping expression of Lgr5 with these “reserve” 
ISC biomarkers; however, Lgr5-negative cell populations have also been shown to 
dedifferentiate in response to damage, suggesting the existence of one or more 
functionally competent ‘facultative’ ISC populations 33, 36, 39. Despite these advances in 
ISC biomarker discovery, FACS isolation and functional characterization of putative 
‘”active” and “reserve/facultative” ISC populations from human intestinal tissue has been 
limited by the lack of validated human ISC biomarkers and in vitro assays to functionally 
test stemness at the single cell level. 
Investigators in other stem cell fields have utilized FACS-based approaches, which rely 
on multiple cell surface antigens, to isolate target stem cell populations of varying purity. 
Notably, biomarkers comprised of cluster-of-differentiation (CD) genes have long been 
used to identify hematopoietic stem cells and their progenitors 132. We recently adopted a 
similar strategy to demonstrate that low levels of CD24 facilitate FACS of Sox9Low/Lgr5+ 
murine ISCs capable of forming enteroids in vitro 21. Similarly, CD44 is expressed in the 
stem cell zone of the murine small intestine and can be used to enrich for Lgr5+ CBCs 
133. In this study we explored whether CD24 and CD44 could be used to FACS-isolate 
human ISCs. 
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RESULTS AND DISCUSSION 
CD24 and CD44 expression was assessed on human jejunum derived from 
patients who had undergone roux-en-y gastric-bypass surgery. Immunostaining 
demonstrates that CD44 is expressed on cells from the base of the crypt to the crypt-
villus junction (Figure 2.1A, C, & E). By contrast, the villus epithelium does not show 
appreciable CD44 staining (Figure 2.1B & D). CD24 demonstrates similar expression to 
CD44 in the epithelium with the notable exception that staining is primarily distributed 
along the apical membrane (Figure 2.1F & H, arrows). A minority population of crypt-
based cells expresses high levels of cytoplasmic CD24 (Figure 2.1G & I, arrows). While 
CD24/44 expression is highly restricted to the stem cell zone in the epithelium, there is 
broad expression in non-epithelial cells in the lamina propria, sub-mucosa, and muscle 
(Figure 2.1A-I). EpCAM (CD326) expression is unique to all crypt and villus epithelial 
cells, and was deemed useful for positive FACS selection to separate epithelial from non-
epithelial CD24/44-expressing cells (Figure 2.1J-L).  
 
Next, we analyzed CD24, CD44, CD45, and CD326 on dissociated single 
epithelial cells (Figure 2.2). Positive selection for epithelial cells (EpCAM+) and 
negative selection for lymphocytes (CD45-) was included in the FACS parameters for 
robust epithelial enrichment (Figure 2.3C). Flow cytometry data demonstrate four distinct 
epithelial cell populations based on CD24/44 expression status (Figure 2.3D). Each of the 
four populations (CD24-/44-; CD24+/44-; CD24-/44+; CD24+/44+) was collected for 
gene expression analysis. Semi-quantitative reverse transcriptase polymerase chain 
reaction (qRT-PCR) validated the FACS by showing enriched gene expression for 
52 
CD24/44 in the appropriate populations (Figure 2.4A & B). The data demonstrate that 
CD24-/CD44+ populations are most enriched for the “active” cycling ISC markers, 
LGR5 and OLFM4 (Figure 2.5A & B); and the CD24+/CD44+ population is most 
enriched for the “reserve/facultative” ISC marker HOPX (Figure 2.5C). Interestingly, all 
CD24+ and CD44+ populations demonstrate significant de-enrichment for Paneth cell 
markers DefensinA6 (DEFA6) (Figure 2.6A) and Lysozyme (LYZ) (Figure 2.6B), and 
goblet cell marker, Mucin2 (MUC2) (Figure 2.6C), all of which associate with CD24 
expression in mice 8, 39, 134. However, the CD24+/CD44+ population is highly enriched 
for the enteroendocrine cell marker Chromogranin A (CHGA) which is consistent with 
observations made in mice (Figure 2.6D) 21.  
 
To test if the CD24-/CD44+ and CD24+/CD44+ populations had functional 
properties of stemness, we subjected isolated single cells to culture conditions similar to 
those that have been successfully used to grow small intestine crypts and single colonic 
stem cells from human tissue 82, 83. Both ISC populations formed appreciable cystic 
enterosphere structures by 48 hrs (Figure 2.7A), while the other populations (CD24-
/CD44- and CD24+/CD44-) failed to do so. Enterospheres derived from CD24-/CD44+ 
cells continued to develop over the first week of culture, while CD24+/CD44+ derived 
enterospheres exhibited a limited increase in size (Figure 2.7A). Nevertheless, both 
populations persisted in culture at 7 days (Figure 2.7B & C). In an attempt to increase 
culture efficiency, we added GSK-inhibitor CHIR99021, which promotes self-renewal of 
embryonic stem cells was recently used to enhance in vitro growth and survival of human 
colon cancer stem cells and intestinal crypts 84, 135, 136. Interestingly, initial GSK-
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inhibition significantly improved 7-day enterosphere survival in the CD24-/CD44+ 
population, but had no appreciable effect on the CD24+/CD44+ population (Figure 2.7B 
& C). Initial GSK-inhibition greatly increased 14-day survival of the CD24-/CD44+ 
population, but was insufficient for the maintenance of CD24+/CD44+ derived enteroids, 
which did not survive to 14 days, regardless of GSK-inhibition (Figure 2.7C). Previous 
studies have shown that Lgr5-negative populations can de-differentiate and function as 
“facultative” stem cells when presented with the proper extrinsic cues 36, 39. Additionally, 
co-culture of primary human intestinal crypts with myofibroblasts enhances culture 
efficiency 137. In an attempt to “activate” the CD24+/CD44+ population, we co-cultured 
the cells with myofibroblasts isolated from human jejunal submucosa. Surprisingly, when 
grown in these conditions, both CD24-/CD44+ and CD24+/CD44+ cells produced long-
lived enteroids, at rates of 0.07% and 0.76%, respectively (Figure 2.8). 
 
To assess multipotency, we retrieved and processed enteroids for 
immunohistochemistry at 21 days. CD24-/CD44+ derived enteroids were epithelial in 
nature (Figure 2.9) and produced enteroendocrine (CHGA), goblet (MUC2), and Paneth 
cells (LYZ), as well as absorptive enterocytes (SIM) (Figure 2.10B). CD24+/CD44+ cells 
grown in co-culture with primary human myofibroblasts exhibited the same 
characteristics of multipotency as CD24-/CD44+ cells (Figure 2.10C and Figure 2.9). 
Enteroids derived from both populations exhibited increased numbers of lysozyme 
positive cells, consistent with results in mice demonstrating that persistent WNT 
signaling, specifically through CHIR99021 treatment, increases Paneth cell production in 
enteroid culture 62. This biased secretory lineage allocation likely explains the rare 
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occurrence of MUC2 positive cells in the enteroids. Importantly, co-culture with 
myofibroblasts did not induce growth in CD24-/CD44- and CD24+/CD44- populations, 
demonstrating that functional stemness under all tested growth conditions remains 
restricted to CD24-/CD44+ and CD24+/CD44+ populations.  
 
The translation of scientific findings made in genetically homogeneous mouse 
models presents investigators with a daunting challenge when attempting to understand 
the vast heterogeneity underlying physiology in human populations. This report provides 
new methodology for epithelial dissociation, isolation, and FACS enrichment of ISCs 
from human small intestine through the use of a combinatorial CD-marker “signature”. 
The ability of CD24 and CD44 to enrich for ISCs is highly consistent with observations 
in mice; however, in stark contrast to findings in mouse models, human Paneth cells do 
not appear to express high levels of CD24, highlighting the need to validate mouse 
genetic biomarkers on human samples 8, 21, 39, 134. Furthermore, our results demonstrate 
variable levels of gene enrichment between some patients. This observation could be 
attributed to a wide range of factors, including phenotypic heterogeneity between 
samples. In the present study, tissue procurement protocols required full de-identification 
of samples; thus, a patient’s dietary habits, state of illness, or medication history could 
not be correlated to gene expression variations. This highlights the need for 
comprehensive studies with controlled enrollment criteria, utilizing the foundation for 
isolation of LGR5 and HOPX-enriched populations, presented here. 
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In addition to FACS-enrichment of ‘active’ LGR5+ ISCs, the CD24/CD44 
approach facilitates differential isolation of HOPX+ cells, which emerging evidence 
suggests may represent facultative ISCs 29. While several of the markers examined here 
exhibit a degree of variability between samples, it is clear that the population of cells 
most enriched for LGR5 is distinct from the population most enriched for HOPX, unlike 
recent observations of Hopx expression in murine Lgr5+ cells 33. Additionally, CD24-
/CD44+ and CD24+/CD44+ populations exhibit differential behavior in vitro, both in 
response to GSK-inhibition and in basal culture conditions required for growth, further 
supporting the existence of phenotypically distinct ISC populations. Though overlap of 
LGR5 expression with putative “reserve” ISC markers in mice remains controversial, our 
data suggests that more distinct populations may exist in the human small intestinal 
epithelium 27, 29, 33, 37. Further work is needed to characterize the CD24+/CD44+ 
population and determine if it is analogous to proposed “facultative” ISCs observed in 
mouse models of intestinal damage and regeneration. Multiple reports have demonstrated 
the ability of Lgr5-negative facultative ISCs to drive regeneration in murine intestine 
following irradiation, suggesting that an analogous population may be of particular 
interest in human pathophysiology, especially in patients undergoing radiation treatment 
for tumors 36, 39. Understanding the genetics and patient-to-patient heterogeneity of 
phenotypically distinct human ISC populations may provide valuable insight toward the 
development of novel clinical diagnostics and therapeutic interventions.  
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MATERIALS AND METHODS 
Patients/Tissue collection and preparation. De-identified tissue from female patients 
ranging between 33-53 yrs of age with body mass indices of 39-60 kg/m2 was used in this 
study. Tissue was obtained from laparoscopic roux-en-y gastric bypass surgery and 
represents jejunal segments of approximately 4 cm in length. Following resection, tissue 
was placed in a specimen cup on ice until a mucosectomy was performed, aided by 
injecting ice-cold saline between the mucosa and submucosa prior to careful dissection. 
Single cell dissociation was carried out on a small portion of the total mucosa (1 cm x 1 
cm) for gene expression studies and a larger tissue area (4cm x 4cm) was dissociated for 
culture experiments. For an informative comparison, the mass of mucosa used for this 
preparation represents approximately 300- and 1200-times the mucosal mass of an 
average biopsy from endoscopy or colonoscopy at UNC (13 mg/biopsy; unpublished, 
Drs. Tope Keku/Robert Sandler), respectively. Following dissection, mucosa was placed 
in 3 mM EDTA in 1x PBS for 45 min at 4°C on a rocker to remove villi. The villus 
fraction was discarded (Figure 2.11A) and the remaining mucosa was then transferred 
into 5 mL of PBS and lightly shaken by hand (approximately 1 shake/sec for 2 min) to 
remove the remaining epithelium (Figure 2.11B). An equal volume of 2% Sorbitol made 
in 1x PBS (Sigma, St. Louis, MO) was added.  To further deplete the solution of 
contaminating villi, the epithelial solution was passed through a 70µm filter. This 
procedure results in a ‘crypt-enriched’ epithelial preparation (Figure 2.11C). The crypts 
were pelleted at 150x g for 10 min at 4°C.  Crypts were then digested to single cells by 
resuspending the pellet in 5 mL of HBSS containing 0.3 U/mL of dispase (Worthington 
Biochemical, Lakewood, NJ) followed by incubation at 37°C for 10 min. The crypt 
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solution was then manually shaken for 30 sec (3-4 shakes/sec). The solution was then 
checked for extent of dissociation to single cells. If cell clumps remained, shaking cycle 
was repeated every 5 minutes, then checked for extent of dissociation. Shaking cycles 
were stopped at the earliest time point at which 80-90% of crypts were dissociated to 
completion or up to 30 min maximum. An average of 1 x 107 cells was obtained from a 1 
cm x 1 cm mucosal segment. Single cells were filtered using a 40µm filter to remove 
undissociated clumps. For FACS, 1 x 107 cells were placed in 500µL of ISC staining 
media (see Flow cytometry section, below) for antibody staining. Human tissue used in 
this study was deemed exempt from full Institutional Review Board review  (approval 
#09-2159).  
 
Immunostaining. A 3 cm square piece of jejunum from each case was fixed with freshly 
made 4% paraformaldehyde (PFA) for a 24–48h at 4°C. The tissues were then prepared 
for cryosectioning by immersion in 30% sucrose for at least 24h at 4°C. Tissues were 
embedded in Tissue-Tek optimal cutting temperature (OCT) medium (Sakura, Torrance, 
CA) and frozen on dry ice. 8–10µm sections were cut on a cryostat and placed on 
positively charged microscope slides. Prior to immunostaining, tissue sections were 
rinsed twice in PBS to remove OCT. Non-specific binding was blocked by applying 
Dako Protein Block (Dako, Carpinteria, CA, X0909) to tissue sections for 30 min at room 
temperature. Primary antibodies were applied in Dako Antibody Diluent (Dako, S0809) 
and incubated for 2h at room temperature. Dilutions were as follows: CD326/EpCAM 
(1:250, clone 9C4, BioLegend, San Diego, CA), CD44 (1:250, clone IM7, BioLegend), 
CD24 (1:100, clone ML5, Biolegend), Lysozyme (1:500, Diagnostic Biosystems, 
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Pleasanton, CA), Mucin2 (1:100, Santa Cruz Biotechnology, Santa Cruz, CA), Sucrase 
Isomaltase A-17 (1:100, Santa Cruz), ChromograninA (1:500, Immunostar, Hudson, WI). 
Anti-Rabbit-Cy3 (1:500 Sigma, St. Louis, MO, C2306) and anti-Rat-Cy3 (1:500 Jackson 
Immunoresearch, Carlsbad, CA, 112-165-003) secondary detection antibodies were 
diluted in Dako Antibody Diluent and applied to tissue for 30 min at room temperature. 
Nuclei were stained for 10 minutes with bisbenzamide (1:1,000, Sigma) diluted in PBS. 
Background staining was negligible as determined by nonspecific IgG staining. Images 
were collected by capturing ~1 µm optical sections using a Zeiss LSM 710 confocal 
microscope.  
 
Flow Cytometry/FACS. Cells were stained for 90 min on ice in ISC Staining Media 
[Advanced DMEM/F12 (Gibco), N2 (Gibco), B27 (Gibco), Glutamax (Gibco), 
Penicillin/Streptomycin (Gibco), 10µM Y27632 (Selleck Chemicals, Houston, TX), 
500mM N-acetyl-cysteine (Sigma), and 10% FBS (Gemini Biosciences)] with the 
following antibodies or isotype controls:  AlexaFluor 647 (Alexa647) conjugated anti-
CD24 [1:100] (clone ML5, Biolegend #311109, San Diego, CA), Pycoerythrin-Cy7 (PE-
Cy7) conjugated anti-CD45 [1.6:100] (Biolegend #304015), Fluorescein isothiocyanate 
(FITC) conjugated anti-EpCAM [4:100](clone 9C4, Biolegend #324203), and Brilliant 
Violet 421 (BV421) conjugated anti-CD44 [0.6:100] (clone IM7, Biolegend #103039). 
For initial analysis by flow cytometry, 1 x106 cells were stained, fixed in 2% PFA for 10 
min at room temperature, then rinsed (with PBS) and resupended in 500 µL of PBS for 
analysis using a Beckman-Coulter (Dako) CyAn ADP (Figure 2.2).  For sorting 
experiments, cells were rinsed and resuspended in ISC Sort/Culture Media [Advanced 
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DMEM/F12 (Gibco), N2 (Gibco), B27 (Gibco), Glutamax (Gibco), 
Penicillin/Streptomycin (Gibco), 10mM HEPES (Gibco), 10µM Y27632 (Selleck 
Chemicals), and 500mM N-acetyl-cysteine (Sigma)].  FACS was conducted using an 
iCyt Reflection (Visionary BioScience) for RNA collection or FACSAria (BD 
Biosciences, San Jose, CA) for cell culture experiments. Dead cells and debris were first 
excluded based on size via bivariate plot of forward scatter (FSC) vs. side scatter (SSC) 
(Supplemental Figure 3A).  Doublets/multimers were excluded using a bivariate plot of 
FSC peak vs. FSC length (Supplemental Figure 3B).  Epithelial cells were FACS-
enriched by sorting EpCAM (CD326) positive, CD45 negative cells (Figure 2.3C).  The 
remaining cell events were analyzed for CD24 and CD44 expression on a bivariate plot 
(Figure 2.3D). Five cell populations: CD45-EpCAM+(whole), CD45-EpCAM+CD24-
CD44-(negative), CD45-EpCAM+CD24+CD44-(CD24+CD44-), CD45-EpCAM+CD24-
CD44+(CD24-CD44+), CD45-EpCAM+CD24+CD44+(CD24+CD44+) were collected 
directly into 500 µl of RNA lysis buffer (Ambion RNAqueous Micro, Grand Island, NY) 
for gene expression analysis. For cell culture experiments, cells were collected into 
500µL of ISC Staining Media.   
 
Primary isolation of human small intestinal myofibroblasts. Following mucosectomy for 
epithelial prep, remnant submucosa (~4cm x 4cm) was diced with a sterile razor blade. 
To eliminate blood cells and remnant epithelium, tissue chunks were washed in 20mL 
DMEM (Gibco), shaken for 2 minutes, and then allowed to settle before supernatant was 
removed and discarded. This process was repeated 8 times. The submucosal tissue was 
then resuspended in 5mL DMEM containing Penicillin/Streptomycin, 0.3U/mL dispase, 
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and 300U/mL collagenase I (Sigma) and rotated for 25 min at room temperature. 10mL 
of DMEM +10%FBS was added to quench the reaction and the tissue suspension was 
pipetted vigorously ~50 times to further mechanically dissociate myofibroblasts. The 
tissue suspension was centrifuged at 300g for 5min and the resulting supernatant and 
tissue remnants were plated separately in DMEM +10%FBS. Media was changed every 
24hrs. Cultures initiated from the supernatant of the prep produced myofibroblasts, which 
were passaged 3 times before use in ISC culture experiments.  
 
Intestinal epithelial stem cell culture. Cells were pelleted and resuspended in ES-
qualified Matrigel (BD Biosciences) containing ISC culture growth factors (see Table 
2.1). For feeder-free cultures, 10µL Matrigel droplets were plated in 96-well plates and 
overlaid with 100µL ISC Sort/Culture Media, with or without 2.5µM CHIR99021 
(Selleck Chemical) following 15 minute of polymerization at 37°C. For feeder co-culture, 
25µL Matrigel droplets were allowed to polymerize in 12-well transwell inserts (BD 
Biosciences) before being placed in wells containing fibroblast feeder cells and 500µL 
ISC Sort/Culture Media. An additional 500µL of the same media was placed in the 
transwell to prevent drying of the Matrigel droplet. CHIR99021 was not used in co-
culture experiments. To facilitate differentiation of enteroids, Wnt3a, SB202190, and 
nicotinamide were withdrawn at 14 days of culture, as previously described for whole 
crypt cultures83.  
 
cDNA preparation/real-time PCR analysis. mRNA from sorted cell populations was 
purified by using RNAqueous Micro Kit (Ambion) according to the manufacturer’s 
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protocols. cDNA was generated using iTaq Reverse Transcription Supermix (Bio-Rad, 
Hercules, CA). Real-time PCR was conducted for each sample in triplicate on 1/20,000 
of the total amount of cDNA generated. Taqman probes [18S, HS99999901; CD24 
Hs00273561_s1; CD44, Hs01075861_m1; LGR5 Hs00173664_m1; OLFM4 
HS00197437_m1; HOPX Hs04188695_m1; DEFA6 Hs00427001_m1; LYZ Hs00426232; 
MUC2 Hs00159374_m1; CHGA Hs00900373_m1] for each gene were obtained from 
Applied Biosystems (Pleasanton, CA) and used in reactions according to the 
manufacturer’s protocol.  
 
Statistical Analysis. qRT-PCR data was normalized for the expression of 18S.  ∆∆Ct 
values were then calculated using the CD24-CD44- (negative) cell population as the 
comparator.  Statistical analysis compared gene expression across all cell populations by 
gene for each patient via one-way ANOVA followed by Bonferroni post-test for multiple 
comparisons between the population of interest and all other populations. Statistical 
analysis was performed in Graph Pad Prism (ver 4.0, LaJolla, CA). 
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Figure 2.1 – CD24 and CD44 are expressed in the stem cell zone of the human intestinal epithelium. Epithelial expression of 
CD44 is restricted to the basolateral membranes of crypt cells (A, C, & E), with no expression in villus epithelium (B & D). CD24 is 
also restricted to the crypt, but is expressed on the apical membrane of epithelial cells (F & H, arrow). A subset of crypt-based 
epithelial cells expresses high levels of cytoplasmic CD24 (G & I, arrows). CD326 (EpCAM) is expressed throughout both the crypt 
and villus, but remains restricted to epithelial cells (J-L). Scale bars represent 50µm. 
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Figure 2.2 – CD45, CD326, CD44, and CD24 antibodies label positive populations 
via flow cytometry. Isotype controls and antibody staining by flow cytometry for CD45, 
EpCAM (CD326), CD44, and CD24 indicate positive staining of populations with 
negligible non-specific labeling.	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Figure 2.3 – CD24 and CD44 differentially label human jejunal cells. Gating strategy for FACS isolation of CD24/CD44+ 
epithelial populations: Removal of debris (A) Singlet gating (B) Selection of epithelial cells by CD45 exclusion and CD326 inclusion 
(C) Sample of gating strategy based on CD24 (y-axis) and CD44 (x-axis) (D). Composition of total jejunal epithelium by CD24/CD44 
expression: table describes % of all gated cells in CD24/CD44 histogram by cell population ± SEM (n=3).  
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Figure 2.4 – CD24/CD44 sorting strategy enriches for CD24- and CD44-positive 
populations. qPCR for CD24 (A) and CD44 (B) demonstrates population-specific 
enrichment for each marker, validating FACS parameters. Letters a-c above each bar 
indicate data points that are statistically different from each other (p < 0.05). 
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Figure 2.5 - CD24-/CD44+ and CD24+/CD44+ intestinal epithelial cells are enriched 
for active and reserve/facultative markers, respectively. CD24-/CD44+ cells are 
significantly enriched for active ISC markers (A) LGR5 and (B) OLFM4, while 
CD24+/CD44+ cells exhibit enrichment for (C) HOPX, which is associated with 
reserve/facultative ISCs. Letters a-d above each bar indicate data points that are 
statistically different from each other (p < 0.05). 
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Figure 2.6 - CD24/CD44 populations are de-enriched for Paneth and goblet cell 
markers. Gene expression analysis demonstrates that CD24 and CD44 populations are 
significantly de-enriched for Paneth cell markers DEFA6 (A) and LYZ (B) and 
demonstrate enriched expression of these markers in CD24/CD44 negative populations 
over whole epithelium. De-enrichment is also observed for goblet cell marker MUC2 (C) 
in two of three cases, with no statistical difference between MUC2 in CD24-/CD44- and 
CD24+/CD44- populations in Case 1, which may be attributable to patient-patient 
heterogeneity. High levels of enteroendocrine marker CHGA are observed specifically in 
the CD24+/CD44+ population in two of three cases, with significant enrichment in 
CD24+/CD44- and CD24+/CD44+ populations in Case 3 (D), consistent with reports in 
mice. Letters a-g above each bar indicate data points that are statistically different from 
each other (p < 0.05). 
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Figure 2.7 - CD24-/CD44+ and CD24+/CD44+ populations generate enteroids in vitro. By 48hrs, CD24-/CD44+ and 
CD24+/CD44+ cells form small enteroid structures, which increase in size over the first week of culture (A). GSK inhibition through 
a single dose of CHIR99021, given when cells are plated, significantly increases 7- and 14-day survival of enteroids derived from 
CD24-/CD44+ cells (B), but has no noticeable effect on the CD24+/CD44+ population (C). While CD24-/CD44+ cells form long-
lived enteroids, the CD24+/CD44+ population does not demonstrate survival at or after 14 days in culture in feeder-free conditions 
(A). Student’s t test was used to determine significance. Asterisks indicate a P-value of  < 0.01.  Scale bars represent 100µm.   
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Figure 2.8 - Co-culture with myofibroblasts induces long-lived enteroid formation in CD24-/CD44+ and CD24+/CD44+ 
populations. Both LGR5-associated CD24-/CD44+ and HOPX-associated CD24+/CD44+ cells form enteroids when co-cultured on 
transwells with myofibroblasts isolated from human jejunal remnants. Enteroids are shown at 14 days post-plating.	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Figure 2.9 - Human enteroids are composed of epithelial cells. Immunofluorescence for EPCAM (CD326) demonstrates that 
enteroids derived from CD24-/CD44+ and CD24+/CD44+ populations are epithelial in nature. Scale bars represent 50µm. 
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Figure 2.10 - Enteroids derived from CD24-/CD44+ and CD24+/CD44+ populations 
are multipotent. Enteroendocrine, goblet, and Paneth cells, as well as absorptive 
enterocytes, are detectable in whole human jejunum by expression of CHGA, MUC2, 
LYZ, and SIM, respectively (A). Similar expression patterns for each marker are 
observed by immunofluorescence in enteroids derived from the LGR5-associated CD24-
/CD44+ population (B) and the HOPX-associated CD24+/CD44+ population (C). Arrows 
indicate positive staining, asterisks mark enteroid lumens, and dotted lines denote outer 
edge of enteroid structures. Scale bars represent 50µm.  
	  
	  
	  72 
	  
	  
	  
	  
	  
	  
	  
Figure 2.11 - Epithelial preparations enrich for stem cell containing crypts. Initial 
shaking steps remove large villi (A). After villus fractions are discarded, additional 
shaking yields both crypts and some remaining villi (B). Filtering results in single 
isolated crypts, with some debris and single cells from submucosal tissues (C).  Scale 
bars represent 100µm. 
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Table 2.1: Culture conditions for human intestinal epithelial stem cell populations. 
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CHAPTER 3 
 
A HIGH THROUGHPUT, CLONAL PLATFORM FOR STUDYING THE 
INTESTINAL STEM CELL NICHE IN VITRO3 
 
 
 
OVERVIEW 
Rapid advances in intestinal stem cell (ISC) biology driven by biomarker 
identification and elegant in vivo lineage-tracing assays indicate that complex niche 
dynamics govern ISC multipotency and self-renewal. While the ISC niche is emerging as 
a key player in the regulation and maintenance of stemness in the intestine, current 
functional assays preclude statistically meaningful studies of single ISCs and ISC-niche 
interactions.  Here we describe the development of an in vitro platform that facilitates 
high-throughput clonogenic culture and computational identification of isolated ISCs and 
niche cells in co-cultures at single cell and microscale (≤ 7 cells) resolution. This new in 
vitro platform has broad applicability in studies aimed at dissecting stem cell 
heterogeneity and stem cell-niche interactions at the single cell level. 
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INTRODUCTION 
Throughout the life of the adult organism, somatic stem cells are responsible for 
maintaining tissue homeostasis following physiological “wear and tear” and damage from 
injury. Understanding how somatic stem cells self-renew and differentiate to produce the 
functional cells of their resident tissue is essential for determining the mechanisms 
underlying a broad range of issues related to human health and disease, including 
degenerative disease, cancer, and aging. Many stem cell types reside within specialized 
niches, where their behavior, including activity/quiescence, self-renewal, and 
differentiation, are likely influenced by extrinsic signaling factors. While the concept of 
stem cell niches was first applied to hematopoietic stem cells, the importance of niche 
cells has now been demonstrated for a number of mammalian tissues, including the brain, 
skeletal muscle, hair follicle, and intestine 46, 138. As signals from the niche are thought to 
play a significant role in modulating stem cell fate decisions in physiology and disease, 
functional assays for studying stem cell response to experimentally modulated signaling 
are invaluable for understanding how stem cells behave in their native environments. 
However, functional stemness remains difficult to study in a statistically meaningful way 
in vitro for many adult tissue types.  
 
 The intestinal epithelium undergoes one of the most rapid rates of renewal of any 
mammalian tissue, making it an excellent model system for understanding stem cell 
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driven physiological renewal. Recent studies demonstrate that crypt-base columnar cells 
(CBCs), marked by high levels of Lgr5 and low levels of Sox9, are capable of driving 
long term regeneration in vivo and formation of “enteroid” structures in vitro, both 
characteristics of functional ISCs 19-21, 24. These CBC ISCs are closely associated with 
Paneth cells, which have been shown to function as niche cells and express soluble and 
insoluble factors associated with stemness, such as Wnt and Notch ligands 8, 62, 70. 
Additionally, Paneth cells have been shown to increase the efficiency of enteroid 
formation by isolated ISCs in vitro 8. 
 
  Though the intestinal epithelium possesses many benefits as a model system for 
somatic stem cell biology, technical limitations hinder efficient and detailed functional 
and mechanistic studies of ISC-niche interactions. While colonic enteroids generated in 
vitro have been successfully transplanted into recipient mice, the field currently lacks a 
robust in vivo transplant assay to study single ISCs at a clonal level, a tool that has driven 
the understanding of stem cell niches in the hematopoietic system, mammary glands, and 
testis 139-141.  
 
  Recently, stem cell-niche interactions in endothelial and spermatogenic cell 
populations have been probed by “recapitulating” the endogenous niche environment in 
vitro through co-culturing strategies 142, 143. Similar studies have examined ISC-Paneth 
cell interactions, both under normal conditions and following calorie restriction 8, 85. 
However, these studies relied on the co-culture of hundreds of ISCs with hundreds of 
Paneth cells, and may not reflect physiologically normal conditions in the intestinal 
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crypts, where much smaller numbers of ISCs and Paneth cells (~15 per crypt) interact 8, 
41, 144.   
 
In the present study, we describe a novel platform to study large numbers of 
single ISCs simultaneously, either at the clonal level or in the presence of one or more 
Paneth cells. Microfabricated culture arrays modified for long-term 3-dimensional culture 
are used to capture and functionally assay single ISCs and clonally derived intestinal 
enteroids. Post-hoc computational identification of initial array contents coupled with 
day-to-day tracking of ISCs and ISC-Paneth cell co-cultures, through the use of unique 
addresses, facilitates the high-throughput analysis of ISC development into enteroid 
structures. To provide proof-of-principle for interrogating ISC-niche interactions, we co-
culture ISCs with Paneth cells and assess enteroid formation from 15 different 
combinations of ISCs and Paneth cell numbers. Surprisingly, we were unable to 
demonstrate a statistically significant correlation between the presence of Paneth cells 
and the likelihood of ISCs to form enteroids. Together, our methodology provides a novel 
platform for high-throughput screening of primary ISCs and in vitro recapitulation of the 
ISC niche, and suggests that ISC-Paneth cell interaction may be subtler than previously 
thought.   
 
RESULTS 
Existing cell culture arrays are adaptable to long-term culture 
Previous studies have utilized microfabricated devices consisting of arrayed 
reservoirs, or microwells, to conduct two-dimensional, adherent cell culture in a 
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microarray format 145. We hypothesized that a similar approach could be utilized to 
isolate and culture single ISCs in three-dimensional extracellular matrix required for the 
growth of primary isolated ISCs. In the present study, we adapted a previously described 
platform, termed microwell arrays, designed for the isolation of viable single cells 
without advanced cell sorting techniques 145, 146. The arrays are fabricated from 
polydimethylsiloxane (PDMS) using standard photolithography and composed of up to 
12,000 microwells (Figure 3.1). As PDMS is known to be a poor substrate for some cell 
types, an additional element (termed microraft) is made from Petri dish grade polystyrene 
and embedded in each microwell of the array using dip-coating methods 145 (Figure 3.1D-
F).  
 
Since ISCs require several days to develop into enteroid structures, microraft 
arrays had to be amenable to media and growth factor changes 21, 24. Additionally, 
separate media compartments were required in order to facilitate simultaneous 
examination of multiple experimental conditions on a single microraft array. To meet 
these requirements, optically clear polycarbonate cassettes, with dividers to create media 
reservoirs (termed culture chambers), were bonded to the microraft arrays (Figure 3.1H & 
Figure 3.2A). Cassettes were fabricated with two (~5,000 microwells per culture 
chamber) and four (~2,500 microwells per culture chamber) culture chambers (Figure 
3.2B). Microwells were sized at 200µm2, with 30µm spacers separating microwells from 
their immediate neighbors (Figure 3.2C). Microwells were designed to have a depth of 
100µm to accommodate enteroid growth. Physical well addresses, stamped into 
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polystyrene rafts at 5 microwell intervals, were included in the array design to allow for 
tracking of unique enteroids across many time points (Figure 3.2C).   
 
To facilitate high-throughput analysis, we used tile-scanning microscopy to 
produce high-resolution, high-magnification images of whole microraft arrays. Initial 
attempts revealed significant out-of-plane sagging in the z-axis, due to the elastic 
property of the PDMS array (Figure 3.2D&F). To prevent sagging of the array during 
imaging, the PDMS template was bonded to a glass slide by using a thin layer of 
polyacrylic acid (PAA) prior to attaching the cassette (Figure 3.1A). Microraft arrays 
bound to glass with PAA, which can be dissolved in PBS to release the array and 
attached cassette from the glass slide, were reproducibly imaged in a single Z-plane by 
tile-scanning without any noticeable out-of-focus sagging (n = 50) (Figure 3.2F&G).  
 
Microraft arrays are biocompatible with long-term three-dimensional ISC culture 
Next, we wished to validate that the PDMS/polystyrene microraft arrays were 
capable of supporting ISC growth and development into enteroids, without cytotoxic 
effects. To facilitate accurate localization of isolated ISCs in the microraft arrays, we 
crossed Sox9EGFP mice to CAGdsRed reporter mice, which express the dsRed 
fluorescent transgene ubiquitously across all cell and tissue types, and isolated Sox9Low 
ISCs from dual transgenic mice by fluorescence activated cell sorting (FACS) (Figure 
3.3A) 21, 147. Additionally, we reasoned that inclusion of a constitutive transgenic reporter 
in the form of dsRed fluorescence would allow us to identify any contaminating GFP-
/dsRed+ non-ISC cell types that may have escaped exclusion from our FACS parameters 
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and could potentially influence functional outcomes. Isolated Sox9EGFPlow:dsRed+ ISCs 
were plated in a single culture chamber of a two-chamber microraft array, randomly 
seeded into microwells by centrifugation, and overlaid with Matrigel containing 
established growth factors mimicking the ISC niche (Figure 3.3B) 8, 84. This plating 
strategy resulted in a random distribution of ISCs across individual microwells within the 
microraft array, with microwells containing one, multiple, or no ISCs (Figure 3.3C-E). 
Tile scanning of the microraft array in the dsRed wavelength immediately after plating 
and at 48hrs of culture revealed that most isolated ISCs had begun to produce primitive 
enteroids, indicative of biocompatibility with the arrays (Figure 3.3F-H).  
 
 Conventional Matrigel-based ISC cultures are capable of supporting enteroid 
growth for many weeks 24, 83. To ask if our microwell array platform was compatible with 
very long-term culture of enteroids, we maintained cultures for extended periods of time. 
Remarkably, enteroids identified at 120hrs after plating were found in the same 
microwells at late culture time points, demonstrating the applicability of address-based 
enteroid identification in long-term culture experiments (Figure 3.3I). At 8 weeks, 
enteroids from isolated ISCs had grown into large structures containing many crypt buds 
and began to spread over the array (Figure 3.3J). Together, these observations 
demonstrate the applicability of the microwell array platform in the long-term culture of 
isolated ISCs, and its potential as a platform for high-throughput chemical screens or 
tissue engineering.    
 
Post-hoc image analysis enables high-throughput identification of single ISCs 
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Closer examination of initial microwell contents in microwell arrays containing 
freshly plated ISCs revealed a number of different content combinations visible in the 
dsRed wavelength. In addition to wells containing isolated ISCs, we observed wells 
containing a combination of ISCs and debris, debris only, as well as some wells 
containing fluorescent artifacts, either as a result of imaging artifacts, or from glare 
generated by the dsRed signal of cells in neighboring microwells (Figure 3.4A). Due to 
the random nature of the ISC plating process in the microwell array platform, we sought 
to develop a semi-automated computational pipeline to achieve the following analytical 
goals: 1) the identification of microwells containing ISCs, 2) the exclusion of empty 
microwells, 3) the exclusion of microwells containing debris or fluorescence 
glare/imaging artifacts, and 4) the quantification of ISCs per microwell in microwells that 
pass exclusion criteria. We divided the pipeline for plating and identification of initial 
microwell contents into five steps: 1) ISC isolation and plating, 2) whole-array image 
acquisition by tile scan imaging and image stitching, 3) segmenting of the processed 
image to individual microwell images with unique addresses, 4) analysis of microwell 
contents using the open-source image analysis package CellProfiler 2.0, and 5) 
reconciliation of CellProfiler data to identify and quantify initial microwell contents 
(Figure 3.4B&C). 
 
 To establish parameters for cell identification and debris discrimination, we 
randomly selected 500 individual microwell images containing single ISCs and 500 
individual microwell images containing debris or fluorescent noise from a two-chamber 
microwell array containing Sox9EGFPlow:dsRed+ ISCs. All analysis was conducted on the 
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dsRed wavelength, since the CAG promoter produced a significantly stronger fluorescent 
signal than the Sox9EGFP BAC transgene. These images were subjected to analysis in 
CellProfiler 2.0, an open source software platform that facilitates computational image 
analysis and can be “trained” to function in specific applications through modulation of a 
number of filtering and analytical parameters 148. We focused on three specific 
parameters to develop an analytical pipeline in CellProfiler to identify ISCs: 
compactness, form factor, and eccentricity. After applying standard image thresholding, 
CellProfiler identified objects in each microwell in our panel of 1000 images, and we 
found that ISCs had a distribution of values that was distinct from debris/noise for each 
of our parameters of interest (Figure 3.4D-F). We used these values to design a 
CellProfiler “pipeline” that identified objects post-thresholding, measured object size and 
shape, determined values for compactness, form factor, and eccentricity, and then filtered 
objects as ISCs or debris based on our established parameters for ISCs (Figure 3.4G). 
Finally, we reconciled the number of objects identified pre- and post-filtering to 
determine which microwells contained debris and which contained only ISCs (Figure 
3.4G).  
 
 In order to validate our ISC identification pipeline using unbiased microwell 
images, we manually scored the contents of 2,254 randomly selected microwells. This 
panel of images was then subjected to analysis using our newly developed pipeline, 
which was able to identify initial microwell contents with a high degree of accuracy, 
especially for microwells containing a single ISC (99.87% accurate) (Figure 3.4H). Due 
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to stringency settings, this accuracy was reduced for wells containing multiple cells.     
  
 
 
Sox9EGFPnegative:CD24high cells represent a highly enriched Paneth cell population 
 Previous studies have isolated Paneth cells from whole intestinal epithelium by 
FACS of CD24High:SSCHigh populations, which have been shown to be enriched for 
Paneth cell markers, including lysozyme 8, 85. However, CD24 is expressed throughout 
the intestinal crypts and is known to enrich for ISCs and TAs in murine and human 
tissue, opening the possibility of contaminating proliferative cells in preparations relying 
on CD24High:SSCHigh sorting parameters 21, 30, 84, 134, 149.  
  
 Since the current study is aimed at examining ISCs and ISC-niche interactions at 
the single cell level, we wished to refine isolation procedures for Paneth cells in order to 
meet the purity requirements of clonal and microscale co-cultures. Interestingly, our 
previous characterization of a Sox9EGFP BAC transgenic mouse model revealed that, 
while endogenous SOX9 marks all cells in the crypt, including Paneth cells, the EGFP 
transgene is preferentially silenced in all Paneth cells, perhaps due to unknown Sox9 
regulatory differences between ISCs/TAs and Paneth cells 35. We reasoned that we could 
exploit this property to isolate a highly pure population of Paneth cells from Sox9EGFP 
mice. To assess relative purity of different Paneth cell isolation methods, we FACS 
isolated putative Paneth cells using conventional CD24High:SSCHigh parameters (Figure 
3.5A&B). We also isolated the same population with the additional exclusion of all 
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Sox9EGFP-positive cells, which should eliminate any contaminating, non-Paneth CD24-
positive cells (Figure 3.5A&C). Gene expression analysis revealed a consistent 2-fold 
increase in lysozyme expression in Paneth cell populations isolated using Sox9EGFP 
exclusion, relative to conventionally-isolated Paneth cell populations (Figure 3.5D). More 
importantly, we noted a nearly 5-fold decrease in Lgr5 expression and a >10-fold 
decrease in Chga in Sox9EGFP-excluded Paneth cells, indicating further de-enrichment of 
ISCs and enteroendocrine cells, respectively (Figure 3.5D). Muc2 expression, associated 
with both goblet and Paneth cells, was unchanged between the two sorting methods 
(Figure 3.5D). Over the course of our co-culture experiments, we examined 2,810 
individual Paneth cells in vitro, and only once observed enteroid production by a putative 
Paneth cell isolated using Sox9EGFP-exclusion parameters, resulting in a functional 
contamination rate of 0.04%, and further supporting the high purity of Paneth cell 
populations isolated using Sox9EGFPneg: CD24High:SSCHigh criteria. 
 
Paneth cells do not significantly influence ISC survival at low cell numbers in vitro 
To establish the utility of the microwell array platform for ISC-niche experiments, 
we co-cultured isolated ISCs and Sox9EGFP-excluded Paneth cells and assessed the impact 
of Paneth cell presence in microwells on the ability of ISCs to form enteroids over 120hrs 
in vitro. In order to confirm that enteroids were formed from bona fide ISCs and not 
contaminating ISCs present in Paneth cell preparations, we isolated ISCs from Sox9EGFP 
or Lgr5EGFP reporter mice and Paneth cells from Sox9EGFP:CAGdsRed dual-positive mice 
(Figure 3.6A). Under this strategy, any enteroids produced by contaminating cells from 
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the Paneth cell preparation would be dsRed+, and excluded from analysis (this was only 
observed once per 2,810 single Paneth cells, as per above).  
 
 Enteroid survival was determined by visual scoring of individual microwell 
addresses at 120hrs and subsequent reconciliation with initial well contents. The 
distribution of ISCs and Paneth cells across the microwell arrays allowed us to examine 
microwells with initial contents consisting of any combination of 1-5 ISCs and 0-2 PCs. 
In order to increase the n per ISC-Paneth cell combination, we conducted two technical 
replicate experiments for each ISC biomarker (Figure 3.6B&C). Examination of survival 
percentages across all combinations of ISCs and Paneth cells revealed no statistically 
significant or visually apparent trends, regardless of whether ISCs were isolated using 
Sox9EGFP or Lgr5EGFP (Figure 3.6B&C). Surprisingly, comparison between some ISC-
Paneth cell combinations revealed seemingly paradoxical results. For example, in one of 
our Sox9EGFPlow-Paneth cell co-culture replicates, the presence of a single Paneth cell 
appeared to decrease percent survival compared to microwells containing a single ISC 
alone (Figure 3.6B). To investigate the overall effect of Paneth cells on enteroid survival, 
we next analyzed the percentage of enteroids formed in microwells containing either 
ISCs alone or ISCs and Paneth cells, regardless of the number of each cell type per 
microwell. These analyses also failed to produce statistically significant differences 
between ISC-only microwells and ISC-Paneth microwells, for both Sox9EGFPlow and 
Lgr5EGFPhigh ISCs, despite examining a high number of microwell replicates per 
condition (Figure 3.6D). In contrast with previous reports, these data suggest that Paneth 
	  86 
cells are not sufficient to increase ISC development into enteroids in vitro, perhaps due to 
an insufficient number of Paneth cells in microwell-based cultures.  
 
 
 
DISCUSSION 
Array based culture platforms for studying ISCs 
Array-based cell culture platforms are growing in use and popularity, and present 
an exciting, high-throughput, and cost-effective alternative to conventional cell culture. 
In stem cell biology, array-based systems have been applied most commonly to ES 
culture. These platforms often utilize printing methods adapted from gene expression 
microarray spotting technology to generate arrays of extracellular matrix (ECM) on glass 
slides, which are then seeded with ES cells and assayed for effects on proliferation and 
differentiation 150, 151. Recent efforts have resulted in the development of advanced 
platforms for microarray-based cell culture that tether ECM molecules to biocompatible 
polymers, such as hydrogels, and have been applied to the culture of multiple stem cell 
types 152, 153. However, these approaches are not amenable to long-term culture 
experiments, such as required for the development of single ISCs into enteroid structures 
154.  
 
 In the present study, we adapt previously described microwell arrays to the long-
term culture of primary ISCs, using established Matrigel-based culture conditions 8, 84. To 
our knowledge, this study represents the first application of high-throughput culture 
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technology to the study of ISCs in vitro. While invaluable in its facilitation of in vitro 
studies on ISCs, the conventional culture system comes with limitations in terms of 
quantification of growth and survival. Previous reports have noted that isolated ISCs can 
merge to form single enteroids in vitro, raising the possibility that the merger of multiple 
ISCs into single enteroids can artificially influence survival data 8. Additionally, the 
inability to follow a statistically meaningful number of individual enteroids over several 
days in conventional Matrigel patties precludes studying more subtle effects on enteroid 
survival and morphology in vitro. Here, we demonstrate methodology compatible with 
following thousands of individual ISCs over multiple days and weeks. In addition to 
applications aimed at dissecting ISC function at the clonal level, the microwell array 
platform facilitates high-throughput screening of potential ISC mitogens and morphogens 
for their effect on enteroid formation and development.  
 
Enhanced isolation of Paneth cells 
In order to allow for the study of ISC-Paneth cell interactions at the single cell 
and microscale level, the present study required isolation of highly pure Paneth cell 
populations. Recent studies have enriched for Paneth cells through the use of the cell 
surface marker CD24, but previous work in our lab and others has demonstrated that 
CD24 is expressed on the apical membrane of all crypt-based epithelial cells 8, 21, 30, 84, 85, 
134, 149. Although CD24 is expressed at varying levels across the intestinal crypts, and 
Paneth cells are further discriminated by increased SSC values, sorting on these 
parameters alone increases the probability of contamination with non-Paneth cell 
populations. In our hands, cultured cells from CD24High:SSCHigh populations routinely 
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produced enteroids in the absence of co-cultured, selected ISCs (data not shown). Here, 
we demonstrate that the further exclusion of the Sox9EGFP transgene increases Paneth cell 
purity by both gene expression analysis and lack of enteroid-forming ability in vitro. This 
technique could be especially valuable to the direct study of Paneth cells in intestinal 
physiology and disease, as transgenic mice for the isolation of Paneth cells based on 
genetic markers are unavailable at this time.  
 
Effects of Paneth cell co-culture on ISC enteroid-forming ability 
The most striking result of our study is the observation that Paneth cells do not 
increase ISC survival in the microwell array platform. One key difference between our 
study and prior studies that demonstrate a positive correlation between Paneth cell co-
culture and enteroid formation by ISCs, is that previous results have relied on the co-
culture of hundreds of cells in a single Matrigel patty. In the present study, we examine 
the impact of no more than 2 Paneth cells on as few as 1 to as many as 5 ISCs. One 
possible explanation for this result is that large numbers of Paneth cells are required in 
order to elicit an impact on ISCs in vitro. In vivo gene expression analysis convincingly 
demonstrates that Paneth cells express critical ISC niche signaling components, including 
Wnt and Notch ligands 8, 62. However, it is clear that niche signals, especially critical Wnt 
ligands, are also produced by non-epithelial sources, including subepithelial 
myofibroblasts 62, 70. Additionally, the effect of the timing of Paneth cell-produced Wnt 
signaling on ISC growth in vitro is unknown. Unlike the addition of exogenous growth 
factors, Wnt3a produced by primary Paneth cells is likely secreted downstream of 
stochastic transcriptional bursting, resulting in waves of ligand production, as opposed to 
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constant secretion 155, 156. This would explain seemingly random patterns of survival in 
the microwell array platform, where ISCs would be exposed to varying levels of Paneth 
cell-produced ligands, the production of which would be the product of stochastic, cell-
autonomous mechanisms intrinsic to individual Paneth cells. In conventional cultures, the 
presence of hundreds of Paneth cells could result in an “averaging” effect, where 
production of ligands by some Paneth cells results in a steady state concentration of niche 
signals, which does not necessarily recapitulate physiological conditions.  
 
 Also surprising was the observation that increased numbers of ISCs per microwell 
at initial time points did not positively correlate with increased enteroid formation at 
120hrs. These data suggest that one of two possibilities. First, is that current ISC 
biomarkers are more broadly expressed than initially appreciated, and mark cells with 
and without genotypic ISC potential. It is also possible that apparent randomness of 
enteroid formation by clonal ISCs reflects the relative rareness and inherent stochasticity 
of functional stemness. These possibilities are both supported by recent observations that 
potency within the ISC niche exists as a complex, shared state between multiple cell 
populations and that ISC-driven clonality is the byproduct of neutral drift dynamics, 
where ISCs are often lost to symmetric differentiation-oriented divisions 34, 37, 39, 41. 
Stemness is defined as the functional ability of a cell to both self-renew and produce all 
differentiated lineages of its resident tissue, though the latter is a characteristic shared by 
some early progenitors that are only distinguished by their lack of self-renewal. Emerging 
data from in vivo studies demonstrates that self-renewal and clonal persistence is a 
characteristic restricted to very small numbers of putative ISCs 44. Since the in vitro 
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culture system for ISCs is a bona fide functional assay of self-renewal, it is also possible 
that our observations mirror similar findings in vivo. 
 
 In summary, the present study establishes methods for the high-throughput culture 
and analysis of ISCs down to clonal resolution. Additionally, we demonstrate a novel 
method for the high purity isolation of Paneth cell populations using previously 
characterized Sox9EGFP transgenic mice. We also demonstrate that Paneth cells do not 
support enteroid formation by ISCs at low cell numbers, and that ISC survival is not 
correlated with the number of ISCs present in a single microwell. Together these data 
suggest that Paneth cells are not sufficient to influence ISC growth at physiologically 
relevant numbers in vitro, and support emerging evidence suggesting that ISC self-
renewal in response to extrinsic signaling is reliant on stochastic intrinsic regulation. 
Further studies examining the response of ISCs to other niche cells, such as subepithelial 
myofibroblasts, will be facilitated by continued use of the microwell array platform.  
  
MATERIALS AND METHODS 
Fabrication of glass mounted microwell arrays 
Materials. SU-8 photoresist was purchased from MicroChem Corp. (Newton, 
Ma).  The Sylgard 184 silicone elastomer kit was purchased from Dow Corning 
(Midland, MI).  γ-Butyrolactone (GBL), octyltrichlorosilane, and propylene glycol 
monomethyl ether acetate were obtained from Sigma-Aldrich (St Luois, MO).  
Poly(acrylic acid) (MW ~5,000) was obtained from Polysciences, Inc. (Warrington, PA).  
Falcon™ Petri dishes were obtained from BD Biosciences (San Jose, CA).  
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Polycarbonate plates (12 inch × 12 inch × 0.5 inch) were purchased from McMaster-Carr 
(Los Angeles, CA) and glass slides (75 mm × 50 mm × 1 mm) were purchased from 
Corning Inc. (Corning, NY). 
 
 Fabrication of glass-backed PDMS microwell array. An SU-8 master mold with 
an array of microposts was fabricated using standard photolithography with 100 µm thick 
SU-8 as described previously 157. The SU-8 master was coated by octyltrichlorosilane 
using vapor deposition to render the surface of the master non-sticky to PDMS 145. Clean 
glass slides (75 mm × 50 mm × 1 mm) were spin coated with a 15-µm thick layer of 
poly(acrylic acid) (PAA) by using 50 wt% solution and a spin speed of 2000 rpm, 
followed by a 1 hr bake on a 100°C hotplate to remove the water.  The slide coated in 
PAA was treated in a plasma cleaner for 10 min (Harrick Plasma, Ithaca, NY).  PDMS 
prepolymer (10 : 1 mixture of base : curing-agent of Sylgard 184 kit) was spread on the 
SU-8 master mold and degassed under vacuum to remove trapped air bubbles.  To control 
the thickness of the PDMS mold, 300-µm PDMS spacers were placed on both ends of the 
master mold.  PDMS spacers were created by spin-coating glass with PDMS prepolymer 
at 200 rpm for 30 s and cured on a 120°C hotplate for 30 min. The plasma-treated PAA-
coated glass slide was then placed on the master mold, flattening the PDMS prepolymer 
between the master mold and the glass slide (Fig. 3.1-A).  The ends of the master-glass 
slide assembly were secured by paper clips to prevent movement during curing of the 
PDMS.  The PDMS was cured in a 95°C oven for 1 hr (Fig. 3.1-B).  The glass-backed 
PDMS microwell array was then obtained by separating the array from the silanized 
master mold (Fig. 3.1-C).  The resulting microwell array has an array area of 25.4 mm × 
	  92 
25.4 mm, and each microwell has a dimension of 200 µm × 200 µm × 100 µm spaced 30 
µm apart.  The PAA layer can later be dissolved in PBS buffer to release the PDMS 
microwell array from the glass backing. 
 
 Micromolding of microwell arrays by dip coating. A polystyrene solution was 
prepared by dissolving polystyrene Falcon™ Petri dishes in GBL at 20 wt% 
concentration.  The polystyrene solution was spread onto the PDMS microwell array and 
degassed under vacuum to remove trapped air bubbles (Fig. 3.1-D).  The glass-backed 
PDMS array was then immersed in the polystyrene solution and withdrawn vertically at a 
speed of 0.83 mm/min by a stepper motor controlled by a custom controller (Fig. 3.1-E). 
Due to surface tension difference between PDMS and polystyrene solution, polystyrene 
solution dewetted from the array, resulted in isolated pockets of polystyrene solution in 
microwells (Fig. 3.1-F). This phenomenon is called discontinuous dewetting 158. The 
array was then placed in a 95°C oven overnight to evaporate the GBL solvent, and 
pockets of polystyrene solution shrunk into solid polystyrene microrafts (Fig. 3.1-G). 
 
Attaching the array to the cassettes. The array was attached to a rigid 2-chamber 
or 4-chamber polycarbonate cassette, which was fabricated by computer numerical 
control (CNC) machine (Fig. 3.1-H). Prior to attachment, the cassette was cleaned by 
sonication in a solution of 1 wt% detergent in water for 1 hr, followed by a 1 hr 
sonication in a 75% ethanol solution.  The cassette was rinsed thoroughly in DI water and 
baked for 15 min in a 95°C oven to remove any remaining solvent.  Both the array and 
the cassette were treated in plasma cleaner for 10 min before being glued together with 
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PDMS (cured in a 95°C oven for 1 hr).  The arrays were treated with air plasma for 5 
min, sterilized with 75% ethanol, and stored in sterile 1X PBS prior to use. 
 
Mice and genotyping 
Sox9EGFP transgenic mice were originally generated by the GENSAT Brain Atlas 
Project, and are maintained on an outbred CD-1 background 159. Lgr5EGFP-CreERT2 mice 
were obtained from Jackson Labs (stock number: 008875, Jackson Laboratory, Bar 
Harbor, ME) 19. For microwell array experiments requiring constitutive expression of 
dsRed in isolated ISCs, heterozygous Sox9EGFP mice were bred to homozygous CAGdsRed 
mice to produce Sox9EGFP:CAGdsRed offspring heterozygous for both alleles. 
Sox9EGFP:CAGdsRed were phenotyped by examining tail snips taken at ~10 days postnatal 
for EGFP and DSRED fluorescence by epifluorescent microscopy. Lgr5EGFP-CreERT2 mice 
were genotyped by previously described PCR protocols 19. All experiments were 
conducted on adult mice between 8 and 16 weeks of age. All protocols for animal use 
were reviewed and approved by the University of North Carolina Institutional Animal 
Care and Use Committee.   
 
Epithelial isolation and FACS 
Epithelial cells were isolated from whole murine intestines, as previously 
described, with some modifications 160. Briefly, intestines were opened longitudinally, 
rinsed in DPBS (Life Technologies, Grand Island, NY), minced, and incubated in 3mM 
EDTA (Sigma, St Louis, MO) in DPBS for 45min at 4°C with gentle agitation. Intestinal 
fragments were transferred to fresh DPBS and shaken by hand for 2 minutes to release 
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epithelium. Remnant submucosa was discarded, epithelium was rinsed twice in DPBS, 
and then dissociated to single cells by incubation in 0.3U/mL dispase (Life Technologies) 
in 10mL HBSS (Life Technologies) at 37°C for 8-10 min with shaking every 2 minutes. 
Single epithelial cells were filtered through 100, 70, and 40µm filters before being 
resuspended in ISC Sort/Culture Media [Advanced DMEM/F12 (Life Technologies), N2 
(Life Technologies), B27 (Life Technologies), Glutamax (Life Technologies), 
Penicillin/Streptomycin (Life Technologies), 10mM HEPES (Life Technologies), 10µM 
Y27632 (Selleck Chemicals, Houston, TX), and 500mM N-acetyl-cysteine (Sigma)]. For 
Paneth cell isolation, cells were resuspended in ISC Sort/Culture Media with 5% FBS 
(Gemini Biosciences) and stained with the following antibodies: Brilliant Violet 
conjugated anti-CD24 (clone M1/69, Biolegend, San Diego, CA); PerCP-Cy5.5 
conjugated anti-CD45 (clone 30-F11, Biolegend). All cells were stained with Sytox Blue 
(Life Technologies) or 7-AAD (Biolegend) and Annexin V-APC (Life Technologies) 
prior to FACS, for live-dead exclusion.  
 
 FACS was conducted on a MoFloXDP (Beckman Coulter, ) and Sox9EGFP and 
Lgr5EGFP cells were isolated as previously described 19, 21, 160. Paneth cells were isolated 
by high expression of CD24, high side-scatter (SSC), and exclusion of CD45, with or 
without exclusion of Sox9EGFP. Cells were collected into ISC Sort/Culture Media for 
array culture and RNaqueous lysis buffer for qPCR analysis (Ambion RNaqueous Micro 
Kit, Life Technologies).  
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Plating ISCs in microraft arrays 
Isolated ISCs and Paneth cells were plated in microraft arrays at ratios of ~1.5 
cells: 1 microwell for ISCs and ~1 cell: 2 microwells for Paneth cells. Sorted cells were 
added to array reservoirs in ISC Sort/Culture Media and cells were seeded into 
microwells by centrifugation at 51g for 5min at 4°C. Following centrifugation, media 
was gently aspirated and arrays were overlaid with 600uL (2 reservoir array) or 200uL (4 
reservoir array) Matrigel containing 1M JAGGED-1 peptide (AnaSpec, San Jose, CA), 
50ng/ml EGF (R&D, Minneapolis, MN), 100ng/ml NOGGIN (Peprotech, Rocky Hill, 
NJ), and 1µg/ml R-SPONDIN1 (R&D). Arrays were centrifuged a second time at 51g for 
5min at 4°C, to recapture any cells displaced by the addition of Matrigel. Matrigel was 
allowed to polymerize for 30min at 37°C before being overlaid with 1mL (2 reservoir 
array) or 600uL (4 reservoir array) ISC Sort/Culture Media. Growth factors, minus 
JAGGED-1 peptide and Y27632, were supplemented every two days, and media was 
changed every 4 days, as previously described 8, 24. 
 
Image acquisition, stitching, and segmenting 
Microwell arrays were tile-scanned in brightfield, GFP, and dsRed wavelengths 
using an automated stage and the Scan Slide function in the Metamorph Imaging Suite 
(Molecular Devices, Sunnydale, CA) immediately after plating and overlaying media. 
Arrays were housed in a physiological chamber mounted on a fluorescent microscope 
during imaging, in order to prevent cell death due to the imaging procedure. Scanned 
images were stitched into a single composite image using the open source image analysis 
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suite FIJI 161 and then segmented into address-associated individual well images using an 
algorithm designed in MATLAB (MathWorks, Natick, MA).  
 
CellProfiler 2.0 analysis 
Computational analysis of initial microwell contents was carried out in 
CellProfiler 2.0 (Broad Institute, Cambridge, MA) in two steps: (1) Segmented microwell 
images were loaded in sequence into CellProfiler to determine the contents of each 
microwell of the array. (2) Raw data generated by CellProfiler was converted into easily 
interpretable graphs and tables displaying the desired location, survivability, or growth of 
ISCs within the array culture.   
 
 Software. Our analysis pipeline (StemCellPipeline) was assembled using modules 
in the open source image analysis software package CellProfiler 2.0 (available for free 
download at http://cellprofiler.org).  
 
 Image thresholding and object identification. Autofluorescence and reflections off 
of microwell walls distort the processed microwell images and can reduce the accuracy of 
stem cell identification. Raw images loaded into CellProfiler undergo thresholding using 
the “MoG Global” method, which separates objects from background based on an 
estimate of the amount of the image occupied by objects. The image occupation of a 
single cell was estimated from 10 microwell images and the threshold correlation factor 
was increased to prevent background identification. A Laplacian of Gaussian algorithm, 
which is best used for objects with increasing pixel intensity towards their center (such as 
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dsRed+ cells), was used to distinguish between single and clumped objects.  
 
 Filtering objects based on characteristics. A panel of 500 microwell images 
containing only one ISC was analyzed using a pipeline containing the CellProfiler 
module “MeasureObjectSizeShape”, which compiled data on the objects’ shape and 
location characteristics. Distribution curves of shape-based parameters of ISCs were 
created and compared to distribution curves generated from a 500-microwell image panel 
of microwells containing debris (Figure 3.4D-F).  Thresholds were set using these 
distribution curves to identify ISCs within total identified objects using the 
“FilterObjects” CellProfiler module (Figure 3.4G).  This filtering allowed us to identify 
the micro-well images containing only intact stem cells and no debris (Figure 3.4G).   
 
Data reconciliation. Data on identified objects and filtered cells contained in each 
microwell image was exported using the “ExportToSpreadsheet” CellProfiler module and 
processed using Microsoft Excel for Mac 2011 (Microsoft, Redmond, WA).  The object 
delimited data exported by CellProfiler is converted to well delimited data using “Excel 
Module1”, which displays the initial contents of each microwell, the distribution of ISCs 
and Paneth cell-containing wells in the array, and the addresses of microwells containing 
cells with no debris or fluorescent noise. 
Statistical analysis of enteroid formation 
Conditional logistic regression was performed with the number of enteroids alive 
at t = 120hr as the response and the number of ISCs and Paneth cells present in initial 
well contents as predictors.   This was done separately for each experiment as well as 
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separately for each replicate within separate experiments.  When analysis was conducted 
across both replicates in a single experiment, a term indicating individual wells was 
included in the model to account for well-to-well variability.   All analyses were 
performed using SAS Version 9.3 (SAS Institute Cary NC).  P-values less than 0.05 were 
considered statistically significant.
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Figure 3.1 – Fabrication of glass-mounted microwell arrays. PDMS is liquid molded onto a PAA-coated glass slide on a SU-8 
master mold (A). PDMS/SU-8 mold assemblies are cured (B), and cured, solid PDMS is gently removed from the mold (C). 
Polystyrene solution is added to the array and degassed (D). Dip coating with a programmed stepper motor removes excess 
polystyrene (D). Subsequent discontinuous dewetting generates isolated polystyrene pockets inside PDMS microwells (F). Arrays are 
baked at 95°C to remove solvent, resulting in solid polystyrene microrafts embedded in PDMS microwells (G). Microraft arrays are 
mounted to polycarbonate cassettes to complete the fabrication process (H). 
	  
	   
100 
	  
	  
	  
 
 
Figure 3.2 – Modified microwell arrays meet requirements for high-throughput cell culture. Completed microwell arrays consist 
of polystyrene-lined PDMS microwells mounted to a glass slide with a thin layer of PAA, and attached to a cassette containing media 
chambers (A). Cassettes can be scaled to divide a single microwell array into 1-4 separate media reservoirs (B). Microwells are 200µm 
square, arranged in a grid, and have physical addresses stamped into polystyrene rafts at 5 well intervals (C). The elastic properties of 
PDMS cause standard microwell arrays to sag, preventing tile-scanned imaging in a single Z-plane (D&F). Mounting arrays to glass 
slides prevents sagging and facilitates imaging (E&G). 
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Figure 3.3 – Microwell arrays are compatible with long-term culture of primary 
ISCs. ISCs are isolated from Sox9EGFP:CAGdsRed transgenic mice, which express dsRed 
throughout the intestinal epithelium, for ease of visualization in microwell arrays, and to 
identify contaminating cell types (A). Isolated cells are seeded into microwells through 
centrifugation in media, and then overlaid with Matrigel in order to meet the 
requirements of primary ISC culture (B). Tile-scan imaging of whole microwell arrays 
immediately following plating demonstrates the random distribution of ISCs across the 
array (C), with some microwells containing single ISCs (D, arrow), and others containing 
multiple ISCs (E, arrowhead). Imaging of the same array at 48hrs reveals widespread 
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enteroid formation (F), with typical cystic growth of early structures (G&H). Long-term 
culture experiments demonstrate that developed ISCs grow out from their original 
microwells over the course of 4 weeks (I), and can be sustained in the array format for 8 
weeks or longer (J).  
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Figure 3.4 – Software-assisted post-hoc analysis identifies initial well contents of 
microwell array culture. A defined workflow facilitates post-hoc image analysis to 
identify well contents in microwell array cultures (A). Tile-scanned images are stitched 
together to form a single composite image, which is then segmented into individual 
microwell images, each with a unique address corresponding to its physical position in 
the array (B). Visual examination of individual microwells reveals the presence of debris 
and fluorescent glare as well as ISCs (C). To distinguish between true ISCs and 
debris/noise, visually scored wells were analyzed by CellProfiler to determine the 
distribution profiles of target events (ISC, blue) and debris (red) for the variables 
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compactness, form factor, and eccentricity (D-F). A novel CellProfiler pipeline that 
identifies objects and applies filters based on the size and shape profiles of known ISCs is 
used to analyze segmented microwell images (G). If the number of objects initially 
identified by CellProfiler is equal to those that pass filtering parameters, the microwell 
passes inclusion criteria (G, top microwell), otherwise it is excluded as debris containing 
or empty (G, middle and bottom microwells). Application of the optimized pipeline to 
randomly selected microwell images reveals an overall accuracy of 99.87%, 71.53%, 
46.51%, and 29.03% for wells containing 1, 2, 3, and 4 ISCs, respectively (H).  
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Figure 3.5 – Sox9EGFP transgenic mice facilitate high purity FACS isolation of 
Paneth cells. To increase population purity, we developed novel FACS criteria for 
Paneth cell sorting. Standard size, double, and live-dead exclusion criteria were applied 
to all FACS isolations (A). We compared putative Paneth cell populations isolated using 
previously described methods, which define Paneth cells as CD24high:SSChigh (B), and our 
newly developed method, which applies the same parameters, but excludes all Sox9EGFP 
expressing cells (C). Gene expression analysis demonstrated significant upregulation of 
Paneth cell marker Lyz2, and downregulation of ISC marker Lgr5, as well as EE cell 
marker Chga in Paneth cell populations isolated with Sox9EGFP exclusion, when 
compared to populations isolated with CD24 and SSC alone (D). 
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Figure 3.6 – Paneth cells do not significantly impact ISC survival at physiologically relevant numbers in vitro. Paneth cells are 
isolated from Sox9EGFP:CAGdsRed mice and co-cultured with ISCs from Sox9EGFP or Lgr5GFP mice lacking the constitutive dsRed 
transgene, allowing for independent tracking of ISC and Paneth cell growth in microwell arrays (A). Quantification of enteroid 
formation across 15 combinations of ISCs and Paneth cells (PC) in experiments using ISCs isolated based on Sox9 and Lgr5 
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biomarker expression demonstrates no significant increase in enteroid formation at 120hr associated with any one condition (B&C). 
Additionally, we were unable to identify any clear trends between Paneth cell number and enteroid development by ISCs. Averaging 
of replicates suggests that formation of enteroids by ISCs occurs randomly in microscale cultures. Analysis of overall enteroid 
formation by ISCs only and ISC-PC co-cultures, regardless of cell number per microwell, also fails to produce a significant effect 
associated with Paneth cell presence (D). 
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CHAPTER 4 
 
SOX4 REGULATES PROLIFERATION, DIFFERENTIATION, AND 5-
HYDROXYMETHYLCYTOSINE PATTERNS IN THE INTESTINAL EPITHELIUM4 
 
 
 
OVERVIEW 
Intestinal stem cells (ISCs) are responsible for maintaining the physiological 
function of the intestinal epithelium through the production of differentiated absorptive 
and secretory cellular lineages. In addition to producing specialized functional cells, ISCs 
must also drive constant proliferation in order to maintain the especially high rate of 
cellular turnover in the intestinal epithelium, which undergoes near total renewal every 5-
7 days. Understanding the transcriptional mechanisms that control how ISCs and transit-
amplifying progenitors (TAs) balance differentiation and proliferation in the intestine 
may provide valuable insight into common pathologies, such as inflammatory bowel 
disease and cancer. Here, we show that the Sry-box containing transcription factor, Sox4, 
is involved in the regulation of proliferation in the ISC/TA zone, the expression of ISC-
associated genes, and the differentiation of enteroendocrine (EE) cells. Interestingly, we 
also observed a significant reduction in the expression of the methylcytosine 
dioxygenase, Tet1, in Sox4-deficient intestines. We find that Tet1, which initiates 
derepression of target genes via DNA demethylation, is specifically upregulated in ISC 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4 full list of contributing authors: Gracz AD, Trotier DC, McCann JV, Harrell C, and 
Magness ST 	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populations in wild-type animals. Additionally, Sox4-deficient intestines showed a 
significant reduction in levels of 5-hydroxymethylcytosine, the catalytic byproduct of 
TET protein activity, in the ISC/TA zone. Together, our data demonstrate that Sox4 
regulates differentiation and proliferation in the intestinal epithelium, and suggests that it 
may influence these processes through induction of Tet1 and subsequent derepression of 
target genes through epigenetic mechanisms.  
 
INTRODUCTION 
The intestinal epithelium is a monolayer of cells arranged along a crypt-villus 
axis, which establishes distinct proliferative and functional compartments in the tissue. 
The villi, which are finger-like structures that protrude into the intestinal lumen, are made 
up of differentiated epithelial cells consisting mainly of absorptive enterocytes, but 
interspersed with secretory goblet cells (mucus-producing) and EE cells (hormone-
producing) 4-6. The crypts are glandular invaginations into the intestinal submucosa, 
which contain the ISC and TA populations, as well as differentiated Paneth cells 
(antimicrobial-producing) 3, 5, 7. Unlike other differentiated lineages, Paneth cells reside at 
the base of the crypt, are intercalated between ISCs, and are thought to generate niche 
cues through soluble and insoluble cell-cell signaling 8. In recent years, efforts in 
biomarker discovery have resulted in the identification of several genetic markers of 
active ISCs phenotypically associated with crypt-base columnar cells (CBCs), including 
Lgr5 and Sox9 19-21. While CBCs are generally appreciated as the primary ISC 
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population, controversy remains over the genetic signature and phenotypic nature of 
reserve, or facultative, ISC populations traditionally associated with the +4 position, 
relative to the base of the crypt. Emerging data suggests that +4 reserve ISCs are actually 
one or more subpopulations of short- or long-lived secretory progenitor cells, that are 
capable of dedifferentiating and exhibiting characteristics of functional stemness 
following radiation damage in vivo or upon exposure to extrinsic signaling cues in vitro 
34, 36, 39. This model of damage response, in which differentiated cells are able to adopt 
stem cell function following injury, is consistent with emerging evidence in other 
epithelial tissues, such as the lung and stomach, and may represent a common mechanism 
for epithelial repair 162, 163. However, little is known about the transcriptional programs 
that control reacquisition of potency or terminal differentiation in intestinal progenitor 
cells.  
 
 Multiple signaling pathways control differentiation, lineage allocation, and 
proliferation in the intestinal epithelium. The Notch pathway is well characterized as a 
central contributor to cell fate decision between secretory and absorptive lineages 
(reviewed by 50). Activation of Notch induces the expression of Hes1, which is associated 
with the production of absorptive enterocytes 78. In the absence of Notch, progenitor cells 
are specified toward a secretory lineage, first through the expression of Atoh1, and later 
through lineage-specific factors such as Ngn3 (enteroendocrine), Spdef (goblet/Paneth), 
and Gfi1 (goblet/Paneth) 81, 164, 165. ISCs express Notch ligands, and are dependent on 
Notch signaling, but appear to rely on downstream effector genes distinct from those 
found in differentiation programs 74, 78. The Wnt pathway, which is critically important 
	  111 
for proliferation and maintenance of stemness in the intestinal epithelium, also plays a 
role in secretory differentiation, as increased Wnt signaling promotes Paneth cell 
maturation 62. 
 
Sox factors are HMG-domain containing transcription factors that participate in 
the processes of progenitor proliferation and differentiation in a broad range of tissues 
throughout development, as well as in adulthood 97, 107. In the intestinal epithelium, Sox9 
has been identified as a Wnt target and ISC biomarker, and distinct levels of Sox9 
expression are differentially associated with ISCs, TAs, EE cells, and Paneth cells 20, 21, 35. 
SOX9 has also been shown to mark DCAMKL1-positive Tuft cells 15. Loss of Sox9 is 
associated with crypt hyperplasia, increased proliferation, and decreased Paneth cell 
numbers, indicating a dual role in ISC/TA proliferation and cell fate specification 108, 110. 
While the expression of other Sox factors, including Sox4, Sox6, and Sox17, has been 
established in the intestinal epithelium, much less is known about their expression and 
function in different cell populations of the intestine 107. Sox4 belongs to the SoxC 
subgroup of Sox factors and plays critical roles in cardiac, hematopoietic, and pancreatic 
development 117, 130. In the gastrointestinal tract, Sox4 is associated with recurrence in 
colorectal cancer (CRC) and has been shown to positively regulate Wnt signaling in CRC 
cell lines 114, 166. However, the role of Sox4 in ISC proliferation and differentiation in vivo 
has not been established.  
 
 Though less appreciated in the context of ISC proliferation and differentiation, 
multiple epigenetic mechanisms are emerging as key determinants of potency and lineage 
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allocation in ESCs and iPSCs. One of the most common epigenetic marks is methylation 
at the 5-position of cytosine (5mC), which is associated with gene repression. 
Accordingly, DNA methylation patterns are known to undergo significant changes during 
the transition from pluripotency to lineage specification, as genes required for 
differentiation become active 167. Recent work has identified the ten-eleven translocation 
(TET) family of proteins, consisting of TET1-3, as enzymes that oxidize 5mC to produce 
5-hydroxymethylcytosine (5hmC), which is associated with increased promoter activity 
and thought to represent an initial step in the derepression of methylated genes 168. Tet1 
also participates in the maintanence of Nanog expression in ES cells by preventing 
methylation of its promoter, indicative of a role in pluripotency 169. Further studies have 
revealed that, in addition to its canonical role as a methylcytosine dioxygenase, Tet1 
plays a role in active repression of direct target genes, through the recruitment of 
polycomb repressor complex (PRC) subunits 170, 171. In vivo studies into the functional 
role of Tet genes remains limited, though recent work has shown that Tet1 participates in 
the maintanence of potency in adult hippocampal progenitors 172. To date, the expression, 
function, and regulation of Tet genes remains unknown in the intestinal epithelium. 
 
In the present study, we show that Sox4 is expressed in ISCs, TAs, and Paneth 
cells. Loss of Sox4 through conditional ablation in the intestinal epithelium results in 
subtle, but significant crypt hyperplasia, and increased proliferation. Additionally, we 
observe defective lineage allocation, with decreased numbers of enteroendocrine cells 
and an expansion of the Paneth cell zone in Sox4-deficient intestines. Gene expression 
analysis also reveals an upregulation of genes associated with absorptive enterocyte 
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differentiation and function, as well as increased expression of genes associated with ISC 
populations. Interestingly, we find that Tet1 is downregulated following loss of Sox4, and 
that Sox4-deficient crypts exhibit significantly fewer 5hmC-positive cells compared to 
controls. Together, our data indicate that Sox4 controls intestinal proliferation, is involved 
in enteroendocrine differentiation, and may participate in these processes through the 
regulation of DNA methylation patterns through Tet1.   
 
RESULTS 
Sox4 is expressed in ISCs and progenitor cells 
Sox4 has previously been identified as a Wnt target gene, suggesting that it is 
expressed in the intestinal crypts. To establish the expression pattern of Sox4, we 
conducted in situ hybridization on intestinal tissue and found that Sox4 mRNA was 
expressed at the base of the crypts, encompassing the ISC, Paneth, and supra-Paneth cell 
positions, consistent with its identification as a Wnt target (Figure 4.1A&B). In order to 
determine the precise expression of Sox4 in crypt-based cell populations, we sorted 
multiple cell populations from Sox9EGFP transgenic mice. We have previously shown that 
distinct levels of Sox9EGFP are associated with active ISCs (Sox9EGFPlow), TAs 
(Sox9EGFPsublow), EEs/reserve ISCs (Sox9EGFPhigh), Paneth cells 
(Sox9EGFPneg;CD24high), and differentiated villus cells (Sox9EGFPneg;CD24neg) (Gracz, 
unpublished data) 21, 35, 36. Interestingly, Sox4 was enriched in ISCs and TAs in a similar 
manner as Sox9, but was not significantly upregulated in Sox9EGFPhigh cells relative to 
Sox9EGFPlow ISCs (Figure 4.1C&D). Unlike Sox9, which is expressed throughout the 
crypts as well as in a subset of villus EE and tuft cells, Sox4 expression was never 
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observed outside of the crypts, which could account for the lack of further upregulation 
of Sox4 mRNA in Sox9EGFPhigh cells 15, 35. To further examine Sox4 expression, we 
conducted immunofluorescence on intestinal tissue and identified two distinct 
populations of SOX4-expressing cells (Figure 4.1E&F). SOX4low cells were found at the 
base of the crypt, in the CBC/Paneth position (+1 to +3 cell positions from the crypt 
base), while SOX4high cells were most often found in the supra-Paneth cell zone, at cell 
positions +4 to +7 (Figure 4.1G). Together, these data demonstrate that Sox4 is enriched 
in previously identified active and reserve ISC populations, as well as TA and Paneth 
cells. Additionally, SOX4 protein is expressed at distinct levels that are differentially 
correlated with the anatomical positions for active and reserve ISCs. This broad 
expression pattern suggests that Sox4 may play multiple, context-dependent roles in 
different cell types.  
 
SOX4high cells are not label retaining  
Recent studies have established two distinct reserve ISC populations associated 
with the +4 position. While both are capable of driving intestinal regeneration following 
damage, one population is short-lived and marked by high levels of the Notch ligand 
Dll1, and the other is long-lived and identified by label retention 34, 39. To determine if 
SOX4 populations are short-lived or label retaining, we implanted osmotic pumps 
containing the thymidine analogue 5-ethynyl-2′-deoxyuridine (EdU) subcutaneously in 
adult mice in order to continuously label all proliferating cells in the intestinal epithelium. 
After 4 weeks of continuous EdU administration, the pumps were removed and animals 
were sacrificed immediately and following 1 and 2 weeks of “washout”. Examination of 
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intestinal tissue obtained immediately following pump removal showed that the EdU had 
successfully labeled a majority of intestinal epithelial cells, with the expected exception 
of some Paneth cells, which can persist for over 4 weeks following differentiation in vivo 
and were likely produced before pump implantation (Figure 4.2A) 7. Colocalization of 
EdU and SOX4 signals demonstrated that 94% of SOX4-positive cells were labeled by 
EdU immediately following pump removal, with the remaining 6% likely made up of 
Paneth cells that differentiated prior to labeling (n = 100 cells) (Figure 4.2A&D). This 
number significantly decreased to 11% and 9% following 1 and 2 weeks of washout, 
respectively (n = 100 cells) (Figure 4.2B-D).  
 
 Since our expression data demonstrated that low levels of Sox4 mark Paneth cells, 
which are known to be long-lived and label retaining, we asked if label-retention in 
SOX4-positive populations was dependent on expression level. Interestingly, we found 
that label retention within SOX4-positive cells was restricted entirely to SOX4low cells, 
which likely represent a long-lived Paneth cell population (Figure 4.2E). In contrast, no 
label retaining SOX4high cells were found at 1 or 2 weeks of washout (Figure 4.2E). 
These data demonstrate that cells expressing high levels of SOX4 are not long-lived in 
vivo and therefore do not represent a label retaining reserve ISC population.  
 
Conditional deletion of Sox4 in the intestinal epithelium 
Constitutive deletion of Sox4 results in embryonic lethality at E10.5, due to 
defects in the cardiac outflow tract that mirror common trunk arterial malformations in 
humans 117. In order to study Sox4 in adult intestine, we crossed mice carrying previously 
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generated floxed-Sox4 (Sox4fl) alleles to mice expressing Cre recombinase under the 
control of the villin promoter (vilCre), which is expressed throughout the intestinal 
epithelium starting at E13.5 173, 174. Sox4fl/fl:vilCre mice were healthy, viable, and born at 
expected genotypic ratios. We confirmed loss of Sox4 expression by qPCR analysis of 
whole jejunal tissue and found that Sox4 was decreased greater than 2-fold in Sox4 
knockout intestines compared to Sox4fl/fl tissue from littermate controls (Figure 4.3A). 
Since Sox4 was still detected in knockout intestines, we wished to determine if ablation 
of Sox4 was mosaic in the intestinal epithelium, similar to Sox9fl/fl:vilCre mice 108. We 
were unable to detect any SOX4 protein in the epithelium of knockout animals by 
immunofluorescence, suggesting that residual Sox4 expression observed by qPCR 
originates from submucosal tissues known to express Sox4, such as lymphocytes and 
peripheral nerves (Figure 4.3B&C) 115, 126.  
 
Loss of Sox4 does not affect expression of SoxC factors 
Sox factors are able to compensate for one another in vivo, and compensation for 
loss of Sox4 by Sox11 has been observed in the developing spinal cord 96. To establish 
whether or not loss of Sox4 in the intestinal epithelium results in compensatory 
upregulation of other Sox factors, we examined the expression levels of Sox11 and Sox12, 
which together with Sox4 make up the SoxC subgroup 88. We did not observe a 
significant difference in the expression levels of Sox11 and Sox12 between knockout and 
control animals (Figure 4.3D). We also examined the expression of Sox9, which belongs 
to a different Sox subgroup, but is associated with a distinct proliferative phenotype, and 
found no difference between knockout and control tissue (Figure 4.3D). These data 
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indicate that loss of Sox4 does not result in upregulation of other SoxC factors or Sox9.   
 
Sox4 deficient intestines exhibit crypt hyperplasia 
Initial examination of Sox4 knockout intestine revealed generally normal 
epithelial architecture, with clearly defined crypt and villus units. However, we noticed 
an apparent increase in crypt size in knockout intestines (Figure 4.4A&B). Quantification 
of crypt and villus size revealed a significant increase in crypt depth in knockout 
intestines relative to controls, while crypt width as well as villus height and width 
remained unchanged (Figure 4.4C&D).  
 
 Since cell size appeared unchanged in knockout tissue, we examined proliferation 
in Sox4 knockout intestines to establish hyperproliferation as the driving force behind the 
observed increase in crypt size. Immunofluorescence was used to detect KI67, which 
labels all proliferating cells, and we quantified the percent of proliferative cells per crypt 
unit. Sox4 knockout crypts were composed of 65.4% ± 1.6 proliferating cells, which was 
significantly greater than the 51.0% ± 1.9 observed in Sox4fl/fl controls (Figure 4.5A-C). 
Since Wnt signaling is the main regulator of proliferation in the intestinal epithelium, we 
examined the gene expression of direct targets of the Wnt pathway in knockout tissue. 
We found that three direct targets of the canonical Wnt/β-catenin pathway, Ccnd1, Myc, 
and Cd44 were upregulated as much as 3-fold in knockout intestine (Figure 4.5D). 
Together, our data demonstrate that loss of Sox4 results in increased proliferation and 
crypt hyperplasia in vivo. These effects may be due in part to increased Wnt signaling in 
Sox4 knockout intestines, and demonstrate that Sox4 is a negative regulator of intestinal 
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proliferation. These results are surprising, in that studies in CRC cell lines demonstrated a 
positive correlation between expression of SOX4 and Wnt target genes, suggesting that 
the role of Sox4 may differ under physiological conditions and following oncogenic 
transformation 114.  
 
ISC marker expression is increased in absence of Sox4 
A majority of established ISC biomarkers have also been identified as targets of 
Wnt signaling, which induces crypt and ISC formation during development 56, 59. To 
determine if the increased Wnt signaling observed in Sox4 knockout intestines is 
associated with an increase in ISC gene expression, we assayed active ISC markers Lgr5, 
Olfm4, and Ascl2, as well as reserve ISC markers Tert, Lrig, and Bmi1. Both the active 
and reserve markers were significantly upregulated in knockout intestines, with the most 
significant upregulation found for Ascl2, which was expressed approximately 2-fold 
higher in knockout intestines compared to controls (Figure 4.6A&B). Therefore, 
increased Wnt signaling observed in Sox4 knockout intestines is correlated with an 
increase in ISC biomarker expression.   
 
Enteroendocrine and Paneth cell differentiation are dysregulated in Sox4 knockout 
intestines 
Next, we wished to examine if loss of Sox4 has an effect on differentiation in the 
intestinal epithelium. Secretory lineage allocation was examined by immunofluorescence 
against MUC2 (goblet cells), CHGA (EE cells), and LYZ (Paneth cells) (Figure 4.7A, C, 
&F). We found no significant difference in the number of crypt- or villus-based goblet 
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cells between knockout and control intestines (Figure 4.7B). Quantification of EE cell 
numbers revealed a significant decrease in the number of villus units containing CHGA+ 
cells (Figure 4.7D). Additionally, while not significant, we did observe a decrease in the 
number of crypts containing CHGA+ cells. Interestingly, the number of EE cells per 
CHGA+ crypt or villus unit was unchanged (Figure 4.7E). That is, while knockout 
intestines exhibited fewer crypt/villus units containing CHGA+ EE cells, the total 
number of EE cells in crypt/villus units containing one or more CHGA+ cells remained 
the same between knockouts and controls. These data suggest that Sox4 contributes to EE 
differentiation in a clonal manner, but is not required for the production of all EE cells. 
Finally, we quantified LYZ+ cells and found an increase in Paneth cell numbers that did 
not reach statistical significance in knockout intestines (Figure 4.7G). However, 
quantification of cell position revealed the presence of LYZ+ cells outside of the 
expected Paneth cell zone in knockout crypts, with some crypts containing Paneth cells as 
high as position +12-13 from the base of the crypt (Figure 4.7H). This increase in Paneth 
cell number is consistent with the observed increase in Wnt signaling in knockout 
intestines, as Wnt is known to drive differentiation and maturation of Paneth cells 62.  
 
 To examine the possible impact of Sox4 on upstream signaling pathways 
associated with lineage allocation, we assessed gene expression of several major 
transcriptional regulators of differentiation in the intestine by qPCR. We found a > 2-fold 
increase in Notch1 expression in knockout tissue and a smaller, but significant increase in 
the downstream target of Notch signaling, Hes1 (Figure 4.8A). Interestingly, Atoh1, 
which is negatively regulated by constitutive expression of Hes1, was not significantly 
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changed, suggesting that the increased Hes1 expression was inadequate to exert a 
negative regulatory impact on Atoh1 (Figure 4.8A) 78. Consistent with our quantification 
data, the goblet cell associated factors, Gfi1 and Spdef, were unchanged, while the EE cell 
associated factor Ngn3, was significantly downregulated in knockout intestine (Figure 
4.8B). Transcription factors associated with the differentiation and function of absorptive 
enterocytes, Cdx2, Elf3, and Sis, were all significantly upregulated in knockout tissue, 
and may reflect the observed increase in Notch1 and Hes1 expression (Figure 4.8C). 
These data suggest that Sox4 has a broad impact on differentiation in the intestinal 
epithelium, affecting secretory and absorptive lineage allocation toward multiple cell 
types, with the notable exception of goblet cells. 
 
Genome-wide expression analysis of Sox4 knockout intestine 
Since our observations suggested that Sox4 exerts a broad influence on 
proliferation and differentiation in the intestinal epithelium, we next sought to identify 
possible regulatory relationships for Sox4, in order to establish a mechanism for these 
observations. To this end, we conducted genome-wide gene expression analysis by 
microarray on RNA isolated from Sox4fl/fl:vilCre knockout intestines and Sox4fl/fl 
littermate controls. These experiments produced reliable signal values for 31,291 genes 
and lncRNAs that were consistently regulated across knockout replicates (Figure 4.9A). 
Of these, 1,546 transcripts were found to be significantly regulated with a false discovery 
rate (FDR) < 5.0. We examined genes that were up- or down-regulated ≥ 2.0 fold with 
FDR < 5.0, and found that a number of transcripts associated with enteroendocrine 
function were significantly downregulated in knockout tissue, consistent with our 
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phenotypic observations (Figure 4.9B). Of these, Nts and Gcg were the most significantly 
downregulated, at -90.91-fold and -37.37-fold, respectively. Additionally, microarray 
analysis revealed a 2.00-fold upregulation of ISC-associated Prom1, as well as Paneth 
cell-associated transcripts Reg3g and Muc4 (Figure 4.8B). Interestingly, we identified the 
ten-eleven translocation transcript Tet1 as being down-regulated 2-fold following loss of 
Sox4 (Figure 4.8B). In ES cells, Tet1 participates broadly in the maintanence of 
proliferation and initiation of differentiation through epigenetic mechanisms involving 
both changes in DNA methylation and recruitment of PRC2 subunits involved in gene 
repression 170, 171. Furthermore, loss of Tet1 in ES cells is associated with defective neural 
differentiation due to inefficient induction of Ngn2 175. We reasoned that Tet1 might play 
a similar role in intestinal potency and differentiation downstream of Sox4.  
 
Tet1 is expressed in ISC populations and downregulated following loss of Sox4 
The expression pattern and characteristics of Tet genes in the intestine have not 
previously been examined. To determine if Tet1-3 are associated with specific cell types 
in the intestinal epithelium, we examined their expression in active ISCs, TAs, 
EE/reserve ISCs, Paneth cells, and differentiated villus cells using previously established 
Sox9EGFP FACS methods 21, 36. We found that Tet2 and Tet3 were expressed throughout 
the intestine, and not significant up- or downregulated in any specific subpopulation of 
epithelial cells (Figure 4.10). However, Tet1 was enriched 8-10-fold in Sox9EGFPlow 
active ISCs and Sox9EGFPhigh EEs/reserve ISCs, relative to Sox9EGFPneg/CD24neg villus 
cells (Figure 4.10). These data are consistent with previous reports that Tet1 is expressed 
in ES cells and downregulated following differentiation 168, 169. 
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Next, we confirmed decreased Tet1 in Sox4 knockout intestines by qPCR, and 
fold an approximately 2-fold decrease in expression (Figure 4.11). Tet2 and Tet3 are 
capable of converting 5mC to 5hmC in a manner similar to that of Tet1 168. To address 
the possibility of compensation for decreased Tet1 by upregulation of Tet2 and Tet3, we 
examined their expression level in Sox4 knockout tissue. While Tet2 remained 
unchanged, we found a small but significant upregulation of Tet3 following the loss of 
Sox4 (Figure 4.11).  
 
Altered expression pattern and decreased levels of 5hmC in Sox4 knockout intestines 
Since 5hmC is the functional product of TET activity, we examined its expression 
pattern to determine if DNA methylation dynamics were altered following the loss of 
Sox4 in the intestine. Immunofluorescence on wild-type control and Sox4fl/fl intestine 
revealed a consistent gradient in 5hmC expression in the epithelium, with low, but 
present levels in the crypts and increasingly stronger expression moving toward the tip of 
the villus (Figure 4.12A). Interestingly, several 5hmC-high cells were observed at the 
crypt base, anatomically and morphologically consistent with Paneth cells (Figure 
4.12B). As expected, the crypts of Sox4fl/fl:vilCre knockout intestines were almost 
completely devoid of 5hmC expression, with the notable exception of 5hmC-high Paneth 
cells at the crypt base (Figure 4.12C & D). Additionally, the gradient of 5hmC expression 
along the crypt-villus axis was perturbed in Sox4 knockout intestines, with 5hmC levels 
becoming more highly expressed further up the villi than in control animals (Figure 
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4.12C). Quantification of the number of crypts containing 5hmC-high expressing cells 
revealed a significant decrease in knockout intestines, while the number of 5hmC-high 
cells per crypt remained approximately the same for crypts containing as least one 5hmC-
high cell (Figure 4.12E & F). Together, these data demonstrate that Tet1 is 
downregulated in Sox4 knockout intestines, resulting in changes in DNA methylation 
patterns along the crypt-villus axis. 
 
DISCUSSION 
Our findings reveal that Sox4 is broadly involved in proliferation and 
differentiation in the intestinal epithelium. Sox4 expression has previously been localized 
to the crypt base, but the precise distribution of its expression pattern across ISC and TA 
populations was not established 131. Here, we demonstrate that Sox4 is specifically 
upregulated in Sox9EGFP populations previously characterized to represent active, CBC 
ISCs and reserve, +4 ISCs/EE cells 21, 35, 36. Analysis of SOX4 protein expression by 
immunofluorescence supports these data, and further suggests that low levels of SOX4 
are associated with active, CBC ISCs and Paneth cells, and high levels of SOX4 are 
associated with reserve, +4 ISCs. Multiple populations of +4 position ISCs have been 
described, with the important functional distinction of in vivo lifespan. Long-lived label 
retaining cells and short-lived Dll1high cells are secretory progenitor populations, and it 
would be consistent with our phenotypic observations for loss of Sox4 that one or both of 
these populations are consistent with the +4 SOX4high population 34, 39. Our label-
retention studies demonstrate that SOX4high cells are not long-lived, which may indicate 
that these cells overlap with the Dll1high facultative ISC population and not the label 
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retaining population. Alternatively, increased SOX4 expression may be consistent with 
the initiation of terminal differentiation, and may mark cells that are no longer 
functionally capable of reverting to an ISC state. While further characterization studies 
are necessary to establish the degree of overlap between Sox4 expression and previously 
characterized reserve ISC populations, the critical functional experiments required to 
examine potency of Sox4-expressing populations remain technologically impossible 
without a Sox4 reporter mouse model that facilitates in vivo lineage tracing.  
  
 Unexpectedly, deletion of Sox4 in the intestinal epithelium resulted in crypt 
hyperplasia and hyperproliferation. Previous studies on the role of SOX4 in human CRC 
cell lines showed that SOX4 was able to directly bind to β-catenin and increase the output 
of a β-catenin reporter construct, leading the authors to conclude that SOX4 is a positive 
regulator of canonical WNT signaling 114. It is possible that Sox4 acts in a context-
dependent manner and therefore, has different functional roles in physiologically normal 
intestine and tumors. As precedence, studies in the nervous system have demonstrated 
that Sox4 has seemingly opposing functions in neurons versus glia. In neurons, Sox4 
induces differentiated neural phenotypes, whereas it promotes an undifferentiated, 
progenitor-like phenotype in glial precursors 124, 127, 128. Our studies support a model 
where Sox4 negatively regulates potency in the intestinal epithelium, suppressing ISC-
associated genes and downregulating Wnt signaling. Since tumorigenesis is known to 
rely on the dysregulation of physiologically active signaling pathways, it is possible that 
CRC cell lines exploit the apparently broad regulatory behavior of Sox4 in order to 
activate or maintain growth pathways. As such, it will be important to examine the role of 
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Sox4 in the development and growth of intestinal tumors in vivo, to determine if 
dysregulation of Sox4 plays a role in tumorigenesis.   
 
 One common theme for the role of Sox4 across many tissues is its involvement in 
differentiation and the establishment of lineage-specific genetic programs. This function 
is true for B and T lymphocytes, as well as retinal, neural, and pancreatic progenitors 124, 
130, 176. Our data indicate a similar role in the intestinal epithelium, in that loss of Sox4 
results in decreased enteroendocrine cell numbers and gene expression, as well as an 
increase in the expression of genes associated with Paneth cells and absorptive 
enterocytes. Interestingly, loss of Sox4 in pancreatic islets results in decreased endocrine 
differentiation as well, and gene expression studies identified Ngn3 as a significantly 
downregulated transcript during the development of Sox4-deficient islets 130. While we 
observed Paneth cells at significantly higher cell positions, and at slightly increased 
numbers in Sox4 knockout crypts, we did not observe any differences in the gene 
expression of upstream transcription factors involved in Paneth cell specification, 
including Spdef, Gfi1, and Sox9 110, 164, 165. One explanation is that the increased Wnt 
signaling in Sox4 knockout intestines is sufficient to induce slightly higher numbers of 
Paneth cells without significantly altering the upstream factors involved in their 
differentiation 65. In this model, Sox4 would indirectly regulate Paneth cell differentiation 
and position through suppression of Wnt signaling. Alternatively, it is possible that Sox4 
suppresses the expression of Paneth cell specific genes, such as Reg3g and Muc4 
independently or downstream of Spdef and Gfi1, and that removal of this inhibition 
influenced more secretory progenitors to adopt a Paneth cell fate in Sox4 knockout 
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intestines. Further studies are needed to establish the precise relationship between known 
secretory transcription factors and Sox4.  
 
 Our gene expression studies identified the gene encoding the TET1 enzyme as a 
significantly downregulated transcript in Sox4 knockout intestines. While TET proteins 
are attracting great interest in the regulation of potency and differentiation in ES cells, 
little is known about their function in vivo. Tet1 has been identified as critical for the 
maintanence of hippocampal progenitors in adult mice, and may play a role, along with 
Tet2, in maintaining potency in pancreatic progenitors 172, 177. In ES cells, Tet1 promotes 
both pluripotency as well as differentiation depending on context, and appears to do so 
through dual functions as a key mediator of DNA demethylation as well as a cofactor for 
PRC2-induced transcriptional repression 170, 171. We found that Tet1 is specifically 
upregulated in ISC populations in the intestine, consistent with results in ES cells and 
hippocampal progenitors. Interestingly, we find that Tet2 and Tet3, which are 
functionally redundant with the methylcytosine dioxygenase activity of Tet1, are not 
specifically enriched in any one intestinal epithelial population, but expressed at equal 
levels across the crypt-villus axis 168. The catalytic byproduct of TET proteins, 5hmC, is 
expressed as a distinct gradient across the crypt-villus axis, with the lowest levels of 
expression observed in the crypts, and the highest levels of expression observed at the 
villus tips. Compellingly, crypts become almost entirely devoid of 5hmC-positive nuclei 
in the absence of Sox4, demonstrating that functional activity of TET proteins in the 
intestinal crypts is dependent on Sox4 expression. 5hmC gradients are still established in 
Sox4 knockout intestines, but are initiated much higher up the crypt-villus axis. We also 
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found a significant increase in Tet3 in Sox4 knockout intestine, which may partially 
compensate for the decrease Tet1. Interestingly, combined deletion of all Tet genes leads 
to impartial embryonic lethality, suggesting that compensation is capable of rendering 
TET proteins dispensable at in an apparently stochastic manner 178. Stochastic 
compensation and effective “rescue” of normal gene expression programs in the absence 
of Tet1 could explain why the few crypt-villus units that do contain EE cells in Sox4 
knockout intestines contain the same number of EE cells as their wild type counterparts. 
Further investigation is needed to determine what regulatory mechanisms may bypass the 
need for Tet1 expression and DNA demethylation through 5hmC in intestinal 
differentiation.  
 
 In summary, we show that Sox4 is required for proper enteroendocrine 
differentiation and participates in the suppression of ISC-associated gene expression. A 
possible unifying mechanism exists in the regulation of Tet1 by Sox4, which may allow 
expression of Sox4 to induce broad, and context-dependent gene regulatory changes 
through epigenetic means. Based on our data, we propose a model in which Sox4 
participates in intestinal epithelial differentiation through the induction of Tet1, 
subsequent initiation of EE-specific genes, and simultaneous repression of gene 
expression programs associated with potency and stemness (Figure 4.13). Further studies 
will be required to discriminate direct and indirect targets of SOX4 and TET1 in the 
intestinal epithelium, as well as establish the methylation status and transcriptional output 
of these loci. Additional studies into possible distinct and redundant functions of different 
Tet genes in the intestinal differentiation will be of great interest in further understanding 
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fate decisions in ISCs and TAs.  
 
MATERIALS AND METHODS 
Mice and genotyping 
Sox4fl mice have been previously described and were the generous gift of V. 
Lefebvre 174. vilCre mice were obtained from Jackson Labs (stock number: 004586, 
Jackson Laboratory, Bar Harbor, ME) 173. Sox9EGFP mice were obtained from the 
GENSAT project 21, 159. Homozygous Sox4fl/fl mice were bred to Sox4fl/fl mice 
heterozygous for vilCre to produce Sox4fl/fl:vilCre-/- (control) and Sox4fl/fl:vilCre+/- 
(knockout) offspring. Genotyping on tail snips procured at ~10 days postnatal and lysed 
for isolation of genomic DNA was carried out by PCR, as previously described 173, 174. 
Genotypes were observed at expected ratios and Sox4 mutant mice appeared normal and 
viable with no overt physiological phenotype. Sox4fl/fl and Sox4fl/fl:vilCre+/- mice were 
maintained on a C57Bl/6 background. Sox9EGFP mice were maintained on a CD-1 
background. All studies were conducted on the jejunum of adult mice between 8 and 20 
weeks of age, and knockouts were matched to littermate controls when possible. In the 
absence of appropriate littermate controls, experiments were conducted on age-matched 
controls. All protocols for animal use were reviewed and approved by the University of 
North Carolina Institutional Animal Care and Use Committee.       
 
In situ hybridization 
In situ hybridization against Sox4 was carried out as previously described 179. 
cDNA templates for probes were kindly provided by M. Wegner 129. Digoxigenin-labeled 
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probes were generated using the Maxiscript in vitro transcription kit (Life Technologies, 
Grand Island, NY) and digoxigenin-labeled UTP (Roche) and hybridized at 60°C for 
~24hrs. Detection was carried out using alkaline phosphatase-conjugated antibodies 
against digoxigenin (11093274910, Roche, Indianapolis, IN) and NBT/BCIP (Sigma, St 
Louis, MO) for visualization of AP. Background was determined to be negligible by the 
lack of appreciable signal in control slides assayed using sense probes.  
 
FACS isolation of Sox9EGFP populations 
Epithelial cells were isolated from the jejunum of mice heterozygous for the 
Sox9EGFP transgene, as previously described, with some modifications 160. Briefly, 
intestines were opened longitudinally, rinsed in DPBS (Life Technologies), minced, and 
incubated in 3mM EDTA (Sigma) in DPBS for 45min at 4°C with gentle agitation. 
Intestinal fragments were transferred to fresh DPBS and shaken by hand for 2 minutes to 
release epithelium. Remnant submucosa was discarded, epithelium was rinsed twice in 
DPBS, and then dissociated to single cells by incubation in 0.3U/mL dispase (Life 
Technologies) in 10mL HBSS (Life Technologies) at 37°C for 8-10 min with shaking 
every 2 minutes. Single epithelial cells were filtered through 100, 70, and 40µm filters 
before being resuspended in ISC Sort/Culture Media [Advanced DMEM/F12 (Life 
Technologies), N2 (Life Technologies), B27 (Life Technologies), Glutamax (Life 
Technologies), Penicillin/Streptomycin (Life Technologies), 10mM HEPES (Life 
Technologies), 10µM Y27632 (Selleck Chemicals, Houston, TX), and 500mM N-acetyl-
cysteine (Sigma)]. Single epithelial cells were stained with the following antibodies: 
Brilliant Violet conjugated anti-CD24 (clone M1/69, Biolegend, San Diego, CA); PerCP-
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Cy5.5 conjugated anti-CD45 (clone 30-F11, Biolegend). Cells were stained with Sytox 
Blue (Life Technologies) or 7-AAD (Biolegend) and Annexin V-APC (Life 
Technologies) immediately prior to FACS, for live-dead exclusion. Sox9EGFP 
subpopulations and Paneth cells were isolated as previously described using a 
MoFloXDP sorter (Beckman Coulter, Brea, CA) (Gracz, unpublished/Chapter 3 of this 
dissertation and 21, 160). Cells were sorted directly into RNaqueous lysis buffer for RNA 
isolation and qPCR analysis (Ambion, RNaqueous Micro Kit, Life Technologies).   
  
Histology and immunofluorescence 
 Mice were euthanized and intestines were carefully dissected and luminal contents 
cleared by gentle syringe flushing with PBS (Sigma). Intestines were divided up by 
segment (duodenum, jejunum, and ileum) and flushed with cold 4% PFA (Sigma), before 
being fixed overnight in 4% PFA at 4°C. Tissue was transferred to 30% sucrose (Sigma) 
in ddH2O for 16-24 hrs before being swiss rolled, embedded in optimal cutting 
temperature (OCT) media (Sakura, Torrance, CA), and frozen on dry ice. 8-10µm 
sections were used for immunofluorescent analyses. Prior to immunostaining, tissue 
sections were rinsed twice in PBS to remove OCT. Non-specific binding was blocked by 
applying Dako Protein Block (Dako, Carpinteria, CA, X0909) to tissue sections for 30 
min at room temperature. Primary antibodies were applied in Dako Antibody Diluent 
(Dako, S0809) and incubated for 1-2h at room temperature. Dilutions were as follows: 
SOX4 (H-90, 1:100, Santa Cruz, Dallas, TX), CD326 (G8.8, 1:250, BioLegend), KI67 
(TEC-3, 1:250, Dako), Lysozyme (RP028, 1:500, Diagnostic Biosystems, Pleasanton, 
CA), Mucin2 (H-300, 1:100, Santa Cruz), ChromograninA (1:500, Immunostar, Hudson, 
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WI), 5hmC (39791, 1:250, Active Motif, Carlsbad, CA). Anti-Rabbit-Cy3 (1:500 Sigma) 
and anti-Rabbit-Biotin (1:100 Jackson Immunoresearch, Carlsbad, CA, 112-165-003) 
secondary detection antibodies were diluted in Dako Antibody Diluent and applied to 
tissue for 30 min at room temperature. For tertiary detection of biotin-conjugated 
secondaries, Streptavidin-AlexaFluor549 (1:500, Jackson Immunoresearch) was applied 
for 30 min at room temperature. Nuclei were stained for 10 minutes with bisbenzamide 
(1:1,000, Sigma) diluted in PBS. Antigen retrieval (required for SOX4, CHGA, and 
5hmC detection) was carried out in Reveal Decloaker Buffer (BioCare Medical, Concord, 
CA) at 120°C for 10 sec and 95°C for 30 sec in a pressure cooker prior to blocking. For 
5hmC staining, tissue samples were incubated with 2N HCl for 10 min, followed by 
neutralization in 0.1M sodium borate 3 x 10 min. Background staining was negligible as 
determined by nonspecific IgG staining. Images were collected by capturing ~1.5 µm 
optical sections using a Zeiss LSM 710 confocal microscope.  
 
EdU labeling and washout experiments 
Osmotic mini-pumps (Alzet, model 1004, 0.11µl/hr, 28days) were subcutaneously 
implanted along the abdomen of wild-type CD-1 mice (8 weeks old) and closed by either 
suture or wound clip. After pump delivery (28 days), osmotic mini-pumps were 
surgically removed (Day 0), wound closed, and a washout period of either 1 or 2 weeks 
was completed prior to sacrifice and tissue collection. EdU detection was carried out as 
per manufacturer instructions using an EdU detection kit (C10337, Life Technologies).  
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Prior to surgery, pumps were filled with a concentrated EdU (Life Technologies, 
E10187) solution based calculations from our previous studies (EdU injections 3 x day 
for 5 days). Calculations to determine concentration to add to pump were based on a 
schedule of 75µg/injection of EdU, with 3 injections per day (totaling 225µg/day). EdU 
was dissolved in 50:50 DMSO:PEG-300 (Spectrum Chemicals P0108, 25322-68-2). 
 
 
RNA isolation and qPCR gene expression analysis 
For gene expression studies comparing knockout and control tissue, RNA was 
isolated from the proximal 0.5 cm of whole jejunum. Briefly, jejunal segments were 
thoroughly flushed with cold PBS to remove luminal contents and mesenchymal and 
pancreatic tissues were dissected off of the intestinal serosa. Jejunal segments were stored 
in RNAlater (Qiagen. Valencia, CA) overnight until RNA was extracted using the 
RNEasy mini kit (Qiagen) and on-column DNase treatment (Qiagen). RNA from sorted 
Sox9EGFP populations was purified using RNAqueous Micro Kit (Ambion) according to 
the manufacturer’s protocols. cDNA was generated using iTaq Reverse Transcription 
Supermix (Bio-Rad, Hercules, CA). Real-time PCR was conducted in SsoFast Probes 
Mix with ROX (Bio-Rad) for each sample in triplicate on 1/20,000 of the total amount of 
cDNA generated (Taqman probes are listed in Table 4.1).  qRT-PCR data was 
normalized for the expression of 18S.  ∆∆Ct values were then calculated using a single 
control (Sox4fl/fl) mouse as the comparator, and significance was determined using 
student’s t-test.  Statistical analysis for Sox9EGFP populations compared gene expression 
across all cell populations by gene via one-way ANOVA followed by post-hoc t-test for 
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multiple comparisons using Prism (GraphPad, La Jolla, CA). p < 0.05 was considered 
significant. All knockout v. control gene expression analyses represent a biological n = 3 
per group.  
 
Gene expression microarrays and bioinformatics analysis 
All tissue samples were profiled using Agilent SurePrint G3 Mouse 8x60K Gene 
Expression Microarrays (Agilent Technologies, Santa Clara, CA, USA) as previously 
described 180. Microarray data are available at the UNC Microarray Database 
(https://genome.unc.edu). Statistical analysis for the microarrays was carried out with R 
v2.15.1.  To utilize the gene expression information, the probes were retrieved and 
filtered by requiring the Lowess normalized intensity values in both sample and control 
to be > 10. In total, 31,291 gene probes had 100% good data for the three arrays used for 
these analyses. A one-class significance analysis of microarrays was then utilized to 
identify genes that up or down regulated in Sox4 knockout mice.  Genes with a false 
discovery rate <5 were considered significant.	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Figure 4.1 – Sox4 in expressed in ISC and progenitor populations. In situ hybridization identifies Sox4 mRNA at the base of the 
intestinal crypt (A&B). qPCR on FACS isolated Sox9EGFP epithelial populations (C) facilitates more precise detection of Sox4 
enrichment in previously established active ISCs (Sox9EGFPlow) and EEs/reserve ISCs (Sox9EGFPhigh) (D). SOX4 protein is expressed 
at two distinct levels in the crypts (SOX4low and SOX4high), with no observable expression in the villi (E&F). SOX4low cells are 
found primarily in the CBC/Paneth cell zone (+1-+3), and SOX4high cells are found primarily in the supra-Paneth cell position (+4-
+7) (n = 3 biological replicates, 10 crypts per mouse) (G). Scale bars represent 50µm; different letters indicate significance between 
groups, p < 0.05. 
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Figure 4.2 – SOX4high cells are not label retaining. Continuous labeling of all dividing cells using subcutaneous EdU mini-pumps 
results in labeling of all intestinal epithelial cells, with the exception of some long-lived Paneth cells (A). The EdU label is 
subsequently diminished following 1 and 2 weeks of washout, at which point only long-lived cells remain labeled (B&C). 
Colocalization of SOX4+ populations with EdU reveals a significant decrease in labeled cells at 1 and 2 weeks of washout (B-D). 
Further assessment of label retention by SOX4 expression level reveals that only SOX4low cells contribute to the label retaining 
SOX4 population at 1 and 2 weeks (n = 100 SOX4+ cells) (E). Scale bars represent 50µm.    
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Figure 4.3 – Conditional deletion of Sox4 does not affect expression of other SoxC factors in the intestinal epithelium. qPCR 
validation of Sox4 ablation demonstrates a >2-fold decrease in Sox4 expression in knockout mice (Sox4fl/fl:vilCre) compared to 
littermate controls (Sox4fl/fl) (A). Confirmation by immunofluorescence reveals that SOX4 is completely lost in knockout animals, 
suggesting that residual Sox4 mRNA is expressed by subepithelial cells (B&C). Expression of other SoxC factors, Sox11 and Sox12, 
as well as Sox9, which has known roles in intestinal epithelial proliferation and differentiation, remains unaffected (D). Scale bars 
represent 50µm; asterisk indicates significance p <0.001; n.s. indicates no significant difference.   
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Figure 4.4 – Sox4 knockout intestines exhibit crypt hyperplasia. Upon histological examination, crypts in Sox4 knockout intestine 
appear larger than those found in controls (A&B). While villus dimensions remain unchanged between knockout and control animals 
(C), the crypts of Sox4 deficient mice are significantly deeper, suggesting changes in proliferation (D). n = 3 biological replicates per 
condition; 20 units per replicate. Scale bars represent 50µm; asterisk indicates significance p <0.01. 
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Figure 4.5 – Sox4 negatively regulates crypt proliferation and Wnt signaling. Detection of all proliferating cells by KI67 shows an 
increase in the proliferative zone of Sox4 knockout intestines, which contain ~15% more proliferating cells than controls (n = 3 
biological replicates per condition; 20 crypts per replicate) (A-C). Increased proliferation is coincident with increased expression of 
downstream targets of canonical Wnt signaling, Ccnd1, Myc, and Cd44 (D). Scale bars represent 50µm; asterisk indicates significance 
p <0.01. 
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Figure 4.6 – ISC biomarker expression is elevated in the absence of Sox4. Consistent with increased proliferation and Wnt 
signaling, Sox4 knockout intestines have upregulated expression of ISC-associated transcripts, including those associated with active 
(A) and reserve (B) ISC populations. Letters denote significance: a = p < 0.01; b = p < 0.05.  
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Figure 4.7 – Sox4 regulates secretory lineage allocation in the intestinal epithelium. Assessment of secretory lineages in Sox4 
knockout intestines demonstrates changes in differentiation patterns. Numbers of crypt- and villus-based MUC2+ goblet cells remain 
unchanged between knockouts and controls (n = 3 biological replicates per condition; 50 units per replicate) (A&B). Identification of 
EE cells by CHGA reveals an appreciable decrease in EE cells in Sox4 knockout intestines (C) and quantification demonstrates a 
significant decrease in the number of villi, but not crypts, that contain CHGA+ cells (D). However, in crypt and villus units that 
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contain at least once CHGA+ cell, the average number of CHGA+ cells remains unchanged between knockouts and controls (n = 3 
biological replicates per condition; 50 units per replicate) (E). LYZ+ Paneth cells appear at greater numbers and at higher cell 
positions in knockout crypts (F), and quantification shows an increase in Paneth cells per crypts in knockout intestines, but does not 
meet statistical significance (G). Paneth cells are, however, found at significantly increased numbers at higher cell positions in 
knockout crypts, especially in what is traditionally considered the supra-Paneth zone (+4-+8) (n = 4 biological replicates per 
condition; 25 crypts per replicate) (H). Scale bars represent 50µm; asterisk indicates significance p <0.05. 
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Figure 4.8 – Expression of transcriptional regulators of differentiation is altered following the loss of Sox4. Analysis of 
upstream pathways involved in intestinal differentiation reveals increased Notch signaling, through upregulated expression of the 
Notch1 receptor and direct Notch target Hes1, while Atoh1 remains unchanged (A). Consistent with histological observations, the 
goblet cell-associated transcription factors Gfi1 and Spdef are unchanged between knockout and control intestines, but EE cell-
associated Ngn3 is significantly downregulated (~2-fold) in knockouts (B). Consistent with increased Notch1 and Hes1 activity, 
absorptive enterocyte transcription factors Cdx2 and Elf3 are upregulated in knockout intestines, as is the functional absorptive 
marker, Sis (C). Letters denote significance: a = p < 0.01; b = p < 0.05.    
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Figure 4.9 – RNA microarray identifies significantly regulated targets of Sox4. Genome-wide gene expression analysis reveals 
reproducible clustering of Sox4 knockout samples (A). Transcripts that meet analytical requirements for significant regulation show 
the greatest downregulation of genes associated with EE cells (Nts: -90.19-fold; Gcg: -37.27-fold), as well as upregulation of ISC- and 
Paneth-associated genes (B). Transcripts with a fold-change ≥ 2.00 and false discovery rate (FDR) < 5.00 were considered 
significantly regulated.  
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Figure 4.10 – Tet1-3 are expressed in intestinal epithelial subpopulations. qPCR on 
FACS isolated Sox9EGFP subpopulations demonstrates that all three Tet genes are 
expressed in the intestinal epithelium. Tet1 is specifically upregulated in active ISCs 
(Sox9EGFPlow) and EEs/reserve ISCs (Sox9EGFPhigh). In contrast, Tet2 and Tet3 are 
detected across all epithelial populations and do not demonstrate significant upregulation 
in differentiated villus cells (Sox9EGFPnegative:CD24neg), TAs (Sox9EGFPsublow), active 
ISCs (Sox9EGFPlow), EEs/reserve ISCs (Sox9EGFPhigh), or Paneth cells 
(Sox9EGFPnegative:CD24high:SSChigh). Different letters indicate significance between 
groups, p < 0.05. ND = not detected.  
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Figure 4.11 – Dysregulation of Tet expression following the loss of Sox4. Tet1 is 
significantly downregulated in Sox4 knockout intestines, consistent with RNA microarray 
data. While Tet2 expression remains unchanged, Tet3 is significantly upregulated, 
suggesting possible functional compensation for decrease Tet1.  
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Figure 4.12 – Sox4 knockout intestines demonstrate reduced 5hmC. Antibody-based detection of 5hmC, the catalytic byproduct of 
TET activity, reveals a gradient of 5hmC intensity across the crypt-villus axis in control animals, with low 5hmC expression in the 
crypt and increasingly intense expression moving toward the villus tip (A). While present, this gradient is disrupted in Sox4 knockout 
intestines, with knockout crypts being almost completely devoid of 5hmC-positive cells, and 5hmC intensity increasing at a slower 
rate up the crypt-villus axis (B). Quantification of 5hmC-high expressing cells, which are consistent with Paneth cells in both 
knockouts and controls as well as upper crypt cells in controls, reveals a significant decrease in this population in knockout crypts (A-
C). However, in knockout crypts that contain at least one 5hmC-high cell, the average number of 5hmC-high cells per crypt unit 
remains unchanged between knockouts and controls (n = 3 biological replicates per condition; 50 crypts per replicate) (D). Scale bars 
represent 50µm; asterisk indicates significance p <0.05.  
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Figure 4.13 – Proposed model for regulation of ISC potency and differentiation by Sox4. Data from Sox4 knockout studies 
suggests that Sox4 regulates the exit of ISCs and early secretory progenitors from functional potency and induces genetic programs 
associated with secretory cell fates, especially favoring of EE cell differentiation. Because TET1 can function epigenetically as both a 
transcriptional activator through DNA demethylation, and a transcriptional repressor through PRC2-mediated histone methylation, it is 
possible that Sox4 simultaneously regulates the loss of potency and acquisition of secretory fate through a single Tet1-dependent 
mechanism. Partial compensation by Tet3 may influence continued Paneth and EE cell differentiation in Sox4 knockout intestines.  
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Table 4.1 – Taqman probes used in gene expression studies 
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CHAPTER 5 
 
SCOPE OF WORK, SIGNIFICANCE, AND IMPLICATIONS FOR FUTURE 
STUDIES 
 
ISOLATION STRATEGIES 
Isolation of human ISCs  
Building on our previous work in murine ISC isolation, the data presented in 
Chapter 2 of this dissertation include isolation methods for human ISCs 21, 149. 
Interestingly, the use of cell surface markers CD24 and CD44 was able to differentially 
enrich for populations with characteristics of active (CD24-/CD44+) and reserve 
(CD24+/CD44+) ISCs from total epithelial preparations 149. The core contribution of 
these data is that they provide methodology for the isolation, genetic analysis, and in vitro 
expansion of primary human ISCs. While previous studies have described culture 
conditions suitable for culturing primary human intestinal crypts, our study represents the 
first to isolate and culture single human ISCs, as well as the first to characterize ISC 
populations with distinct genetic and functional characteristics in humans 83.    
 
 Interestingly, human CD24 did not enrich for LYZ or DEFA transcripts, 
suggesting a key difference between murine Paneth cells, which are known to express 
CD24, and human Paneth cells, which appear to be CD24-negative. One possibility we 
considered is that the qPCR probes employed in our study do not detect variants of LYZ 
and DEFA in human Paneth cells. We did, however, co-stain histological sections from 
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the same tissue samples that were subjected to FACS isolation and gene expression 
analysis. Confocal microscopy appears to indicate that LYZ+ human Paneth cells are 
indeed CD24-negative, as we never observed CD24+ staining on these cells (Figure 5.1). 
More comprehensive studies involving 3D reconstruction allowing for examination of the 
entire Paneth cell apical membrane are required to confirm these preliminary 
observations. Additionally, these studies would benefit from the use of additional CD24 
antibodies, to assure that these data are not the result of the current antibody being unable 
to detect a splice variant of CD24 expressed on human Paneth cells.  
 
Improved isolation of Paneth cells from murine intestine 
In addition to the new isolation methods for human ISCs described in Chapter 2, 
we also presented methodology for the isolation of high purity Paneth cell populations 
from murine intestinal epithelium (Chapter 3). Paneth cells are implicated in a wide range 
of physiological and disease functions in the intestine, ranging from contribution to the 
ISC niche to interaction with the commensual intestinal microbiome, but studies on their 
molecular and genetic function are limited by the lack of Paneth cell specific reporter 
mice 13. In our study, we take advantage of an earlier observation that Sox9EGFP 
transgenic mice accurately report expression of Sox9 through EGFP expression in all 
cells of the crypt, with the notable exception of Paneth cells 35. This allowed us to further 
purify Paneth cells from CD24-based FACS parameters by excluding any contaminating 
ISCs, TAs, or enteroendocrine cells. Our results, presented in Chapter 3, demonstrate a 
significant de-enrichment of contaminating cell markers, including Lgr5 (ISCs) and Chga 
(EE cells). Recent studies have demonstrated some overlap between Paneth cell markers, 
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Lgr5, and Chga, suggesting that Paneth cells may express some level of these genes in 
vivo, and possibly explaining why these genes were detected at any level in our Paneth 
cell population 34.  
 
INTRINSIC REGULATION OF POTENCY IN ISCS 
Transcriptional regulation of differentiation by Sox4 
In order to address intrinsic regulation of potency in ISCs, we examined the role 
of Sox4 in the intestinal epithelium. While multiple Sox factors are expressed in the 
intestine, information regarding their function remains largely unknown 107. The only Sox 
factor that is well characterized in the intestinal epithelium is Sox9, which is involved in 
negatively regulating proliferation and plays a role in Paneth cell differentiation 108, 110. 
Additionally, Sox9 is expressed throughout the crypt, and distinct expression levels of 
Sox9 facilitate differential isolation of ISCs, TAs, EE cells, Paneth cells, and 
differentiated villus-based epithelium 21, 35, 36. We originally became interested in Sox4 
due to preliminary data demonstrating restricted expression at the crypt base, as well as 
multiple studies in a wide range of tissue systems that implied a role for Sox4 in stem cell 
potency and differentiation (Magness, unpublished) 117, 118, 120, 125, 130, 181. We originally 
hypothesized that Sox4 and Sox9, as the predominantly expressed Sox factors in the 
intestinal crypt, might play opposing roles, with Sox4 acting as a positive regulator of 
proliferation. This model would have been in agreement with in vitro studies in CRC cell 
lines that demonstrated positive regulation of canonical Wnt signaling by SOX4 through 
direct binding and enhancement of β-catenin activity 114. We were surprised at our initial 
results, which reveal an opposite function. Together, our studies establish novel roles for 
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Sox4 as a mediator of ISC/TA proliferation, EE cell differentiation, and Paneth cell 
position in the intestinal epithelium. We also observe changes in gene expression 
programs associated with absorptive enterocytes, suggesting that Sox4 may also regulate 
this lineage.   
 
 Lingering questions from the studies presented in Chapter 4 of this dissertation 
include those focused on understanding the precise mechanisms through which Sox4 
controls proliferation and differentiation. Under our current working model, we 
hypothesize that loss of Sox4 causes differentiation of intestinal stem and progenitor cell 
populations to become inefficient (Figure 5.2). In this model, ISCs/TAs are still capable 
of differentiation through compensatory means, but the process takes place in a delayed 
manner, as unknown compensatory mechanisms are less efficient at inducing 
differentiation that Sox4. Precedence is found in studies that demonstrate that the loss of 
closely related SoxC factor Sox11 causes delayed differentiation in retinal progenitors 176. 
Under these assumptions, the proliferative defect in Sox4-knockout intestines would be 
the indirect result of accumulating progenitor cells (Figure 5.2B). This could also explain 
the small, but significant increase in ISC markers, as well as increased Wnt signaling. 
Further examination of Wnt signaling components in Sox4-knockout intestines hints at 
compensation. Our data demonstrate significant upregulation of the WNT co-receptors 
Lrp6 and Fzd5 in Sox4-knockout mice, but also show an upregulation of the ubiquitin 
ligase Znrf3, which negatively regulates Wnt signaling by targeting receptor complexes 
for ubiquitin-dependent degradation (Figure 5.3) 182. In order to further understand the 
apparently complex regulatory network governed by Sox4, we are currently conducting 
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ChIP-seq experiments to identify direct targets of SOX4, which can then be correlated 
with our gene expression data to determine the transcriptional function of SOX4 at target 
loci. In the absence of ChIP data for SOX4, we were able to identify Tet1 as a candidate 
target of the Sox4 regulatory network. We propose that Sox4 mediates ISC/TA 
differentiation upon upregulation by inducing Tet1 and initiating depression of 
differentiation-associated genes through DNA demethylation (Figure 5.2A). Interestingly, 
timing of retinal differentiation by Sox11 may also be mediated through epigenetic 
mechanisms, perhaps suggesting a common theme for SoxC factors in differentiation 176.  
 
While the data presented here suggest a regulatory relationship between Sox4 and 
Tet1, further studies are needed to confirm this relationship. Although a standard in vitro 
approach using established CRC cell lines would arguably be the most straightforward, 
previously published studies demonstrate a fundamentally different role for Sox4 in CRC 
cell lines than we found in vivo 114. Due to the possibility that Sox4 behaves differently in 
normal tissue in vivo and in cancer cell in vitro, results from such studies might not 
accurately portray the physiological function of Sox4. Several recent reports have 
described methods for gene expression in primary intestinal cultures using viral vectors 
183, 184. We are currently optimizing these protocols in our lab, and future studies will 
focus on confirming our in vivo observations that Sox4 positively regulates Tet1. We plan 
on inducing expression of Sox4 to determine if this results in an increase in Tet1 and 
subsequent expression of EE cell associated genes. Concomitant inhibition of Tet1 using 
siRNA could be employed to test if Sox4 induction of EE differentiation is dependent on 
Tet1 expression, as hypothesized in our model (Chapter 4). 
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Possible roles for Sox4 in epithelial regeneration 
One avenue of study, which is not addressed in this dissertation, is the possible 
role of Sox4 in intestinal epithelial regeneration following damage. The most commonly 
employed model for intestinal regeneration is irradiation damage, which induces well-
defined stages of p53-dependent and p53-independent apoptosis and proliferation in 
murine intestine 185-187. Interestingly, in vitro studies focused on the role of SOX4 in DNA 
damage response demonstrated that the SOX4 protein directly binds to and stabilizes P53 
following irradiation damage, and that this interaction is required to induce p53-
dependent apoptosis 188. Our preliminary data demonstrate that apoptosis is indeed 
decreased in the crypts of Sox4fl/fl:vilCre mice at 4.5hr following 12Gy irradiation, 
compared to Sox4fl/fllittermate controls (Figure 5.4). However, the long-term implications 
of this reduction in initial apoptosis are unclear. Does loss of Sox4 reduce radiosensitivity 
in a physiologically beneficial manner, or does the observed reduction in apoptosis cause 
defective regeneration by genetically compromised cells at later time points? Further 
investigation into the in vivo role of Sox4 in intestinal regeneration is warranted.     
 
 Loss of Sox4 may also affect intestinal regeneration through apoptosis-
independent mechanisms. Our current working model of Sox4-mediated differentiation 
hypothesizes that the loss of Sox4 results in the build-up of uncommitted progenitor cells 
that harbor some degree of ISC marker expression (Figure 5.2B). Additionally, our 
observations demonstrate lineage allocation defects in EE cells and Paneth cells (Chapter 
4). Recent studies have shown that secretory progenitors with EE cell/Paneth cell 
	  155 
potential are capable of dedifferentiation and ISC function following irradiation damage 
34, 39. If loss of Sox4 results in the increase of these cell numbers, it is possible that 
regeneration would proceed at an accelerated rate in Sox4-knockout intestines, as the 
starting pool of facultative ISCs would be greater than in control mice. Studies aimed at 
culturing DLL1High and Sox9EGFPhigh cells isolated from Sox4fl/fl:vilCre intestinal 
epithelium are currently underway to determine if ISC potential is increased in these 
populations under physiological conditions 36, 39. These studies would lay the groundwork 
for further investigation of regulation of facultative stemness by Sox4 in the setting of 
irradiation injury.  
 
Epigenetic regulation of ISC-associated genetic programs by Tet1 
Regulation of DNA methylation by TET proteins is currently attracting significant 
interest in the fields of epigenetics and embryonic stem cell (ESC) biology. From a 
biochemical standpoint, the identification of TET enzymes, which oxidize 5mC to 
produce 5hmC, addresses important questions regarding the demethylation and 
subsequent derepression of methylated genes 168. Multiple high impact studies are 
characterizing the impact of Tet function in the establishment and maintanence of 
pluripotency in ESCs, as well as in the initiation of differentiation. In addition to these 
studies, emerging work is characterizing the role of Tet in cancer and adult stem cell 
populations, including hematopoietic stem cells and neural stem cells 189. The present 
study is, to our knowledge, the first to examine Tet genes in the intestinal epithelium.   
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 We find that all three Tet genes are expressed in the intestinal epithelium (Chapter 
4). However, the expression patterns of Tet2/3, which are expressed at apparently equal 
levels throughout the epithelium, differ from that of Tet1, which is specifically 
upregulated in Sox9EGFPlow and Sox9EGFPhigh ISC and ISC/EE cell populations. These 
data suggest a differential role for Tet1 that is unique to ISCs. Since 5hmC expression is 
observed throughout the intestinal epithelium, it is possible that Tet1 establishes 5hmC 
marks in ISCs/TAs, and Tet2/3 are redundantly responsible for maintaining and/or 
amplifying these marks in villus cells, which express higher 5hmC levels. Interestingly, 
Sox4-knockout mice, which demonstrate significant downregulation of Tet1 still have 
substantial 5hmC expression in villi, despite delayed establishment of the 5hmC crypt-
villus gradient. We find that Tet3 is upregulated in the absence of Sox4, suggesting some 
degree of functional compensation for Tet1. Studies are underway to examine the 
expression of Tet1-3 in Sox9EGFP subpopulations isolated from Sox4fl/fl:vilCre mice, to 
determine if Tet loss and compensation occur in specific epithelial compartments.  
 
 The functional and mechanistic implications of Tet-mediated demethylation are 
perhaps so captivating because of the potential reached by broad, epigenetic 
transcriptional regulation. TETs are capable of activating genes associated with either 
potency or differentiation through a single DNA methylation-related mechanism 169, 175, 
190. Adding another level of epigenetic complexity to transcriptional regulation by TETs 
is their demonstrated ability to affect gene repression through recruitment of PRC2 
complexes and subsequent methylation of core histones 170, 171. The potential of TETs to 
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regulate gene expression at the level of both DNA and histone methylation implies 
central and important roles for these proteins in the regulation of stem cell behavior.  
 
 Establishing Tet1 as a direct target of Sox4 would provide valuable insight into 
the mechanism by which Sox4 influences intestinal differentiation, and imply a broad role 
for Sox4 in the initiation of epigenetic changes that influence ISC behavior. We are 
currently conducting parallel ChIP-seq experiments to identify direct targets of both Sox4 
and Tet1 in the intestinal epithelium. Reconciliation of these data with our RNA 
microarray data from Sox4 knockout intestines will provide valuable insight into the 
shared Sox4-Tet1 regulatory network. If Tet1 is confirmed as a target of Sox4, then future 
studies would benefit from identifying which direct targets of Tet1 are regulated in 
response to induction by Sox4. Since Tet1 is involved in a broad range of gene regulatory 
processes, it would be important to establish if Sox4 is involved in all Tet1-mediated 
signaling in ISCs, or just a subset.  
 
 It would be of great interest to determine if Tet1 is a conserved target of Sox4 in 
other tissues as well. The ability of Sox4 to act indirectly through broad epigenetic 
regulatory elements could help explain its diverse functions across different tissue types 
and in tumors. The availability of floxed Sox4 alleles and tissue specific Cre driver 
mouse lines would facilitate relatively easy investigation in this area.  
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OUTSIDE INFLUENCES: THE IMPACT OF EXTRINSIC FACTORS ON ISC 
BEHAVIOR 
Differential requirements for distinct populations of human ISCs 
In Chapter 2 of this dissertation, we present data that demonstrate the differential 
isolation of two distinct human ISC populations. Initial gene expression studies led us to 
hypothesize that CD24-/CD44+ and CD24+/CD44+ populations were unique from one 
another given differential enrichment of LGR5, which is associated with active CBC 
ISCs, and HOPX, which is associated with +4 reserve ISCs 19, 29. However, controversial 
genome-wide gene and protein expression studies have suggested that ISC biomarkers 
associated with reserve cells, including Hopx, Bmi1, Tert, and Lrig are not expressed 
separately from Lgr5 in mice 33. Therefore, we sought to establish a difference between 
CD24-/CD44+ and CD24+/CD44+ human intestinal epithelial populations through 
functional assays. We found that active-associated CD24-/CD44+ cells are functionally 
responsive to GSK-β inhibition, while reserve-associated CD24+/CD44+ cells are not 149. 
Co-culture with subepithelial myofibroblasts in the absence of GSK-β inhibition was 
sufficient to induce growth and multipotency in CD24+/CD44+ cells 149. Remarkably, the 
reserve-associated cells, which did not exhibit any long-term growth in the absence of 
myofibroblasts, survived at higher rates than the active-associated cells in co-culture 
conditions 149. These data suggest different extrinsic signaling requirements for active and 
reserve human ISCs and provide novel insight into functional differences between these 
two populations.  
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CHIR99021: Wnt-driver or black flag operative? 
While CHIR99021, which potently inhibits GSK-β, is a critical component in the 
culture of primary human ISCs, its exact mechanism of action remains unclear. In studies 
focused on the expansion of murine hematopoietic stem cells and ISCs in vitro, the 
beneficial effects of CHIR99021 have been attributed to the stabilization of β-catenin and 
increase in canonical Wnt signaling through the inhibition of the β-catenin destruction 
complex, which contains GSK-β 84, 191. However, these studies do not address the effect 
of GSK inhibition on insulin signaling, which has been shown to be a critical mitogenic 
pathway in the intestine that drives ISC expansion and may also be an important mediator 
of CHIR99021’s effects on ISCs in vitro 192. In our studies, presented in Chapter 2 of this 
dissertation, we obtained tissue specimens from morbidly obese patients. After several 
initial attempts at culturing isolated cells from these specimens failed, we reasoned that 
defective insulin signaling, a common clinical sequelae of obesity, could be contributing 
to cell death in vitro. We initially tried to supplement our cultures with high doses of 
exogenous insulin, but noticed no change in survival (data not shown). However, 
CHIR99021 was capable of potently increasing survival of the CD24-/CD44+ active ISC 
population 149. We found this result interesting in light of the fact that the cultures already 
contained high doses of recombinant WNT3A and RSPO1, both potent drivers of 
canonical Wnt signaling. These observations may suggest that the tissue used in our study 
was largely resistant to exogenous insulin, a characteristic associated with clinical 
obesity, and that addition of CHIR99021 helped support ISC survival and growth through 
bypassing and acting downstream of the insulin receptor complex. Further research in 
this area is also warranted by the observation that human ISC populations are 
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differentially responsive to CHIR99021, which may provide valuable insight into ISC 
population dynamics in human physiology and disease.   
 
Paneth cells and the possibility of niche function 
One of the most unexpected results presented in this dissertation is the finding 
that Paneth cells do not promote the formation of enteroids by single ISCs in vitro 
(Chapter 3). These data are in conflict with previous reports that the niche signaling 
produced by Paneth cells, particularly in the form of WNT3A, is critical for enteroid 
establishment and development in vitro 8. However, experiments demonstrating increased 
ISC growth in the presence of Paneth cells have previously relied on the co-culture of 
very large cell numbers 8, 85. Our study is the first, to our knowledge, to examine co-
cultures of ISCs and niche cells at physiologically relevant numbers. As such, it is 
possible that very high numbers of Paneth cells are required to induce an effect on ISCs 
in vitro. Additionally, when we isolated Paneth cells using previously described 
CD24high:SSChigh methods, we observed a significant amount of growth from 
contaminating ISCs in the Paneth cell preparation (data not shown). This may partially 
account for the increased survival observed in previous studies.  
 
 An additional possibility that may account for the lack of a significant increase in 
ISC survival in the presence of Paneth cells is that direct cell-cell contact is required for 
this effect. Though not definitively proven, previous studies have hinted at this 
requirement, as Paneth cells are known to produce Notch ligands 8. We are currently 
analyzing the data presented here with the additional criteria of cell-cell contact between 
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ISCs and Paneth cells. These data will allow us to compare the survival percentages of 
ISCs and Paneth cells based on direct contact, and may reveal a significant increase in 
enteroid formation dependent on cell-cell contact. If so, these data would establish a 
mechanism for the enhancement of ISC growth by Paneth cells in vitro.  
 
ISC culture methods and recapitulation of the stem cell niche in vitro 
Another novel method presented in this dissertation is the establishment of a high-
throughput culture platform for clonal ISC growth (Chapter 3). This is the first 
methodology that allows for confirmed clonal analysis of ISCs in vitro, as well as the first 
to facilitate high-throughput screening of ISCs. Future applications will include screening 
of proteins and small molecules to determine their effect on single ISCs. Additionally, 
this methodology is applicable to the in vitro reconstitution of the ISC niche. While the 
proof of principle data presented here focus on Paneth cells, we have begun preliminary 
studies to examine the impact of subepithelial myofibroblasts on ISCs in the microwell 
array platform. Myofibroblasts are known to secrete different WNT ligands than Paneth 
cells, though it is unknown if the functional effect of varying ligands differs in vitro 62. 
Ongoing efforts are also focused on the retrieval of early enteroids using the raft retrieval 
technology integrated into the microwell array platform 145. Single enteroid retrieval is 
being combined with microfludic-assisted gene expression analysis to determine the 
genetic regulatory programs underlying enteroid development.   
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Sox4 as a Wnt and Bmp response element in ISCs and progenitors 
Understanding how the intrinsic regulation of differentiation by Sox4 is affected 
by extrinsic cues is critical to establishing a comprehensive role for Sox factors in 
intestinal epithelial physiology. Previous studies have established that Sox4 can respond 
to both Wnt and Bmp signaling pathways, though it remains unknown precisely how 
these pathways impact the induction of Sox4 and downstream gene activation in the 
intestinal epithelium 56, 120, 193. We are currently conducting in vitro studies aimed at 
determining the response of Sox4 to WNT3A and BMP4 using Sox4-knockout and 
control enteroids. These data will shed light on the upstream regulatory elements 
involved in Sox4 signaling and establish how the loss of Sox4 may impact major 
signaling networks in the intestinal epithelium.  
 
KEY FINDINGS 
1. Cell surface markers facilitate enrichment of active and reserve human ISC 
populations (Chapter 2). 
2. CD24 does not mark human Paneth cells (Chapter 2).  
3. Differential culture requirements for active and reserve human ISCs (Chapter 2).  
4. Development of a high-throughput, clonogenic platform for ISC culture (Chapter 
3). 
5. High purity isolation of murine Paneth cells using Sox9EGFP transgenic mice 
(Chapter 3).  
6. Paneth cells do not support ISC growth at physiologically relevant numbers in 
vitro (Chapter 3). 
	  163 
7. Sox4 is preferentially enriched in ISC and TA populations (Chapter 4).  
8. SOX4 is expressed at different levels in CBC and +4 positions (Chapter 4). 
9. SOX4high cells are not label-retaining (Chapter 4). 
10. Sox4 negatively regulates proliferation in the intestinal crypts (Chapter 4).  
11. Sox4 is involved in EE cell (positive regulation), Paneth cell (negative regulation), 
and absorptive enterocyte (negative regulation) differentiation, and not involved 
in lineage specification of goblet cells (Chapter 4).  
12. Sox4 negatively regulates Wnt signaling and ISC gene expression (Chapter 4).  
13. Sox4 positively regulates Tet1 and contributes to DNA methylation dynamics in 
the intestinal crypts (Chapter 4).  
14. Tet1 is preferentially enriched in ISCs; Tet2/3 are expressed throughout the 
intestinal epithelium (Chapter 4).  
15. Tet3 may be able to partially compensate for a reduction in Tet1 expression levels 
(Chapter 4). 
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Figure 5.1 – Human Paneth cells do not express CD24. Immunofluorescence against 
CD24, which is expressed on the apical cell membrane throughout the intestinal crypts, 
demonstrates that human Paneth cells do not express CD24 (arrows), but are intercalated 
between CD24+ cells (arrowheads).  
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Figure 5.2 – Working model for indirect regulation of ISC potency by Sox4. Our data 
suggest that, under physiologic conditions, Sox4 is expressed at low levels in ISCs and 
upregulated in secretory progenitor cells, which may be consistent with previously 
described facultative ISCs (A). Increased Sox4 expression induces high levels of Tet1, 
which influence EE cell differentiation through the epigenetic derepression of EE-
associated transcription factors, such as Ngn3 (A). In the absence of Sox4, cells are 
eventually able to differentiate through compensatory mechanisms, but inefficient gene 
regulation leads to delayed differentiation and increased numbers of secretory 
progenitors, which also exhibit lingering expression of ISC genes and may by 
functionally competent following injury (B).  	  
	  
	  
	  
	  166 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
Figure 5.3 – WNT receptor complexes and their negative regulators are upregulated 
in Sox4 knockout intestines. Sox4 knockout intestines show significant upregulation of 
the WNT coreceptors Lrp6 and Fzd5. Znrf3, a ubiquitin ligase that participates in the 
active degradation of Fzd5, is also upregulated in knockout intestines, suggesting partial 
compensation in the presence of increase Wnt signaling. 
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Figure 5.4 – Apoptosis is impaired in Sox4 knockout intestines following 12Gy γ-
irradiation. Examination of apoptosis by immunofluorescent detection of cleaved 
caspase-3 at 4.5hr post-12Gy irradiation reveals reduced apoptotic response in Sox4 
knockout intestines. 
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